flavor	drug	concentration	run	tech_repl	hit	category	result	expected	n	n_total	fraction	n_repl
absolute	Acarbose	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	20	0.9	6
absolute	Acarbose	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	20	0.1	6
absolute	Acarbose	5	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
absolute	Acarbose	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	20	0.9	6
absolute	Acarbose	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	20	0.1	6
absolute	Acarbose	5	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
absolute	Acarbose	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	20	0.85	6
absolute	Acarbose	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	20	0.15	6
absolute	Acarbose	5	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
absolute	Acarbose	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	20	0.85	6
absolute	Acarbose	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	20	0.15	6
absolute	Acarbose	5	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
absolute	Acarbose	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	20	0.85	6
absolute	Acarbose	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	20	0.15	6
absolute	Acarbose	5	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
absolute	Acarbose	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	20	0.85	6
absolute	Acarbose	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	20	0.15	6
absolute	Acarbose	5	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
absolute	Acarbose	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	16	0.8125	6
absolute	Acarbose	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	16	0.1875	6
absolute	Acarbose	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	5	0.4	6
absolute	Acarbose	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	5	0.6	6
absolute	Acarbose	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	16	0.875	6
absolute	Acarbose	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	16	0.125	6
absolute	Acarbose	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	5	0.2	6
absolute	Acarbose	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	5	0.8	6
absolute	Acarbose	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	16	0.8125	6
absolute	Acarbose	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	16	0.1875	6
absolute	Acarbose	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	5	0.2	6
absolute	Acarbose	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	5	0.8	6
absolute	Acarbose	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	16	0.875	6
absolute	Acarbose	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	16	0.125	6
absolute	Acarbose	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	5	0.2	6
absolute	Acarbose	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	5	0.8	6
absolute	Acarbose	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	16	0.75	6
absolute	Acarbose	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	16	0.25	6
absolute	Acarbose	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	5	0.4	6
absolute	Acarbose	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	5	0.6	6
absolute	Acarbose	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	16	0.75	6
absolute	Acarbose	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	16	0.25	6
absolute	Acarbose	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	5	0.4	6
absolute	Acarbose	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	5	0.6	6
absolute	Acarbose	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	14	0.8571428571428571	6
absolute	Acarbose	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	14	0.14285714285714285	6
absolute	Acarbose	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	7	0.42857142857142855	6
absolute	Acarbose	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	7	0.5714285714285714	6
absolute	Acarbose	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	14	0.8571428571428571	6
absolute	Acarbose	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	14	0.14285714285714285	6
absolute	Acarbose	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	7	0.2857142857142857	6
absolute	Acarbose	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	7	0.7142857142857143	6
absolute	Acarbose	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	14	0.7857142857142857	6
absolute	Acarbose	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	14	0.21428571428571427	6
absolute	Acarbose	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	7	0.2857142857142857	6
absolute	Acarbose	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	7	0.7142857142857143	6
absolute	Acarbose	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	14	0.7857142857142857	6
absolute	Acarbose	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	14	0.21428571428571427	6
absolute	Acarbose	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	7	0.42857142857142855	6
absolute	Acarbose	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	7	0.5714285714285714	6
absolute	Acarbose	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	14	0.7142857142857143	6
absolute	Acarbose	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	14	0.2857142857142857	6
absolute	Acarbose	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	7	0.5714285714285714	6
absolute	Acarbose	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	7	0.42857142857142855	6
absolute	Acarbose	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	14	0.7857142857142857	6
absolute	Acarbose	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	14	0.21428571428571427	6
absolute	Acarbose	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	7	0.5714285714285714	6
absolute	Acarbose	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	7	0.42857142857142855	6
absolute	Amlodipine	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
absolute	Amlodipine	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Amlodipine	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
absolute	Amlodipine	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
absolute	Amlodipine	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
absolute	Amlodipine	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
absolute	Amlodipine	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
absolute	Amlodipine	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
absolute	Amlodipine	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
absolute	Amlodipine	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
absolute	Amlodipine	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
absolute	Amlodipine	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
absolute	Amlodipine	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	6	1	6
absolute	Amlodipine	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	15	0.26666666666666666	6
absolute	Amlodipine	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	15	0.7333333333333333	6
absolute	Amlodipine	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	6	1	6
absolute	Amlodipine	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	15	0.26666666666666666	6
absolute	Amlodipine	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	15	0.7333333333333333	6
absolute	Amlodipine	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	6	1	6
absolute	Amlodipine	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	15	0.4	6
absolute	Amlodipine	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	15	0.6	6
absolute	Amlodipine	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	6	1	6
absolute	Amlodipine	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	15	0.3333333333333333	6
absolute	Amlodipine	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	15	0.6666666666666666	6
absolute	Amlodipine	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	6	1	6
absolute	Amlodipine	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	15	0.26666666666666666	6
absolute	Amlodipine	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	15	0.7333333333333333	6
absolute	Amlodipine	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	6	1	6
absolute	Amlodipine	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	15	0.2	6
absolute	Amlodipine	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	15	0.8	6
absolute	Amlodipine	160	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Amlodipine	160	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	18	0.7222222222222222	6
absolute	Amlodipine	160	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	18	0.2777777777777778	6
absolute	Amlodipine	160	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Amlodipine	160	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	18	0.7777777777777778	6
absolute	Amlodipine	160	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	18	0.2222222222222222	6
absolute	Amlodipine	160	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Amlodipine	160	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	18	0.6111111111111112	6
absolute	Amlodipine	160	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	18	0.3888888888888889	6
absolute	Amlodipine	160	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Amlodipine	160	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	18	0.7777777777777778	6
absolute	Amlodipine	160	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	18	0.2222222222222222	6
absolute	Amlodipine	160	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Amlodipine	160	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	18	0.7777777777777778	6
absolute	Amlodipine	160	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	18	0.2222222222222222	6
absolute	Amlodipine	160	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Amlodipine	160	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	18	0.7777777777777778	6
absolute	Amlodipine	160	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	18	0.2222222222222222	6
absolute	Aprepitant	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	20	0.85	6
absolute	Aprepitant	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	20	0.15	6
absolute	Aprepitant	5	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
absolute	Aprepitant	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	20	0.75	6
absolute	Aprepitant	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	5	20	0.25	6
absolute	Aprepitant	5	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Aprepitant	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	20	0.85	6
absolute	Aprepitant	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	20	0.15	6
absolute	Aprepitant	5	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Aprepitant	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	20	0.75	6
absolute	Aprepitant	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	5	20	0.25	6
absolute	Aprepitant	5	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Aprepitant	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	20	0.55	6
absolute	Aprepitant	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	9	20	0.45	6
absolute	Aprepitant	5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Aprepitant	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	20	0.55	6
absolute	Aprepitant	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	9	20	0.45	6
absolute	Aprepitant	5	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Aprepitant	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	11	0.8181818181818182	6
absolute	Aprepitant	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	11	0.18181818181818182	6
absolute	Aprepitant	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	10	0.4	6
absolute	Aprepitant	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	10	0.6	6
absolute	Aprepitant	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	6
absolute	Aprepitant	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	6
absolute	Aprepitant	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	10	0.4	6
absolute	Aprepitant	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	10	0.6	6
absolute	Aprepitant	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	11	1	6
absolute	Aprepitant	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	10	0.2	6
absolute	Aprepitant	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	10	0.8	6
absolute	Aprepitant	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	6
absolute	Aprepitant	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	6
absolute	Aprepitant	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	10	0.4	6
absolute	Aprepitant	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	10	0.6	6
absolute	Aprepitant	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	11	0.6363636363636364	6
absolute	Aprepitant	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	11	0.36363636363636365	6
absolute	Aprepitant	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	10	0.4	6
absolute	Aprepitant	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	10	0.6	6
absolute	Aprepitant	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	11	0.7272727272727273	6
absolute	Aprepitant	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	11	0.2727272727272727	6
absolute	Aprepitant	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	10	0.4	6
absolute	Aprepitant	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	10	0.6	6
absolute	Aprepitant	30	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	4	0.75	6
absolute	Aprepitant	30	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	4	0.25	6
absolute	Aprepitant	30	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	17	0.29411764705882354	6
absolute	Aprepitant	30	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	17	0.7058823529411765	6
absolute	Aprepitant	30	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	4	0.75	6
absolute	Aprepitant	30	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	4	0.25	6
absolute	Aprepitant	30	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	17	0.29411764705882354	6
absolute	Aprepitant	30	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	17	0.7058823529411765	6
absolute	Aprepitant	30	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	4	0.75	6
absolute	Aprepitant	30	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	4	0.25	6
absolute	Aprepitant	30	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	17	0.29411764705882354	6
absolute	Aprepitant	30	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	17	0.7058823529411765	6
absolute	Aprepitant	30	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	4	4	1	6
absolute	Aprepitant	30	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	17	0.29411764705882354	6
absolute	Aprepitant	30	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	17	0.7058823529411765	6
absolute	Aprepitant	30	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	4	0.75	6
absolute	Aprepitant	30	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	4	0.25	6
absolute	Aprepitant	30	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	17	0.35294117647058826	6
absolute	Aprepitant	30	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	17	0.6470588235294118	6
absolute	Aprepitant	30	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	4	0.75	6
absolute	Aprepitant	30	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	4	0.25	6
absolute	Aprepitant	30	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	17	0.29411764705882354	6
absolute	Aprepitant	30	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	17	0.7058823529411765	6
absolute	Aripiprazole	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Aripiprazole	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Aripiprazole	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Aripiprazole	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Aripiprazole	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Aripiprazole	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Aripiprazole	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Aripiprazole	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Aripiprazole	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Aripiprazole	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	21	0.8571428571428571	6
absolute	Aripiprazole	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	21	0.14285714285714285	6
absolute	Aripiprazole	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Aripiprazole	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Aripiprazole	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	21	0.8095238095238095	6
absolute	Aripiprazole	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	21	0.19047619047619047	6
absolute	Aripiprazole	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Aripiprazole	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Aripiprazole	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Aripiprazole	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
absolute	Aripiprazole	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
absolute	Aripiprazole	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	21	0.8571428571428571	6
absolute	Aripiprazole	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	21	0.14285714285714285	6
absolute	Aripiprazole	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Aripiprazole	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	18	18	1	6
absolute	Aripiprazole	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	3	0.6666666666666666	6
absolute	Aripiprazole	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	3	0.3333333333333333	6
absolute	Aripiprazole	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	18	0.2222222222222222	6
absolute	Aripiprazole	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	18	0.7777777777777778	6
absolute	Aripiprazole	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Aripiprazole	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	18	0.1111111111111111	6
absolute	Aripiprazole	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	16	18	0.8888888888888888	6
absolute	Aripiprazole	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Aripiprazole	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	18	18	1	6
absolute	Aripiprazole	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	3	0.6666666666666666	6
absolute	Aripiprazole	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	3	0.3333333333333333	6
absolute	Aripiprazole	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	18	0.05555555555555555	6
absolute	Aripiprazole	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	17	18	0.9444444444444444	6
absolute	Aripiprazole	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	3	0.3333333333333333	6
absolute	Aripiprazole	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	3	0.6666666666666666	6
absolute	Aripiprazole	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	18	0.05555555555555555	6
absolute	Aripiprazole	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	17	18	0.9444444444444444	6
absolute	Azithromycin	2.5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Azithromycin	2.5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	15	20	0.75	6
absolute	Azithromycin	2.5	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	20	0.25	6
absolute	Azithromycin	2.5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Azithromycin	2.5	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	20	0.7	6
absolute	Azithromycin	2.5	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	20	0.3	6
absolute	Azithromycin	2.5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Azithromycin	2.5	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	17	20	0.85	6
absolute	Azithromycin	2.5	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	20	0.15	6
absolute	Azithromycin	2.5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Azithromycin	2.5	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	16	20	0.8	6
absolute	Azithromycin	2.5	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	20	0.2	6
absolute	Azithromycin	2.5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Azithromycin	2.5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	15	20	0.75	6
absolute	Azithromycin	2.5	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	20	0.25	6
absolute	Azithromycin	2.5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Azithromycin	2.5	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	15	20	0.75	6
absolute	Azithromycin	2.5	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	20	0.25	6
absolute	Azithromycin	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	18	21	0.8571428571428571	5
absolute	Azithromycin	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	21	0.14285714285714285	5
absolute	Azithromycin	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	18	21	0.8571428571428571	5
absolute	Azithromycin	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	21	0.14285714285714285	5
absolute	Azithromycin	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	18	21	0.8571428571428571	5
absolute	Azithromycin	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	21	0.14285714285714285	5
absolute	Azithromycin	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	18	21	0.8571428571428571	5
absolute	Azithromycin	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	21	0.14285714285714285	5
absolute	Azithromycin	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	18	21	0.8571428571428571	5
absolute	Azithromycin	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	21	0.14285714285714285	5
absolute	Azithromycin	50	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	18	21	0.8571428571428571	6
absolute	Azithromycin	50	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	21	0.14285714285714285	6
absolute	Azithromycin	50	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	18	21	0.8571428571428571	6
absolute	Azithromycin	50	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	21	0.14285714285714285	6
absolute	Azithromycin	50	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	18	21	0.8571428571428571	6
absolute	Azithromycin	50	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	21	0.14285714285714285	6
absolute	Azithromycin	50	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	18	21	0.8571428571428571	6
absolute	Azithromycin	50	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	21	0.14285714285714285	6
absolute	Azithromycin	50	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	18	21	0.8571428571428571	6
absolute	Azithromycin	50	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	21	0.14285714285714285	6
absolute	Azithromycin	50	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	18	21	0.8571428571428571	6
absolute	Azithromycin	50	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	21	0.14285714285714285	6
absolute	beta-estradiol 17-valerate	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	beta-estradiol 17-valerate	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
absolute	beta-estradiol 17-valerate	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
absolute	beta-estradiol 17-valerate	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	beta-estradiol 17-valerate	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	beta-estradiol 17-valerate	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	beta-estradiol 17-valerate	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	beta-estradiol 17-valerate	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	5	7	0.7142857142857143	6
absolute	beta-estradiol 17-valerate	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	7	0.2857142857142857	6
absolute	beta-estradiol 17-valerate	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	14	0.35714285714285715	6
absolute	beta-estradiol 17-valerate	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	14	0.6428571428571429	6
absolute	beta-estradiol 17-valerate	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	4	7	0.5714285714285714	6
absolute	beta-estradiol 17-valerate	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	7	0.42857142857142855	6
absolute	beta-estradiol 17-valerate	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	14	0.35714285714285715	6
absolute	beta-estradiol 17-valerate	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	14	0.6428571428571429	6
absolute	beta-estradiol 17-valerate	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	5	7	0.7142857142857143	6
absolute	beta-estradiol 17-valerate	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	7	0.2857142857142857	6
absolute	beta-estradiol 17-valerate	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	14	0.42857142857142855	6
absolute	beta-estradiol 17-valerate	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	14	0.5714285714285714	6
absolute	beta-estradiol 17-valerate	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	5	7	0.7142857142857143	6
absolute	beta-estradiol 17-valerate	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	7	0.2857142857142857	6
absolute	beta-estradiol 17-valerate	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	14	0.42857142857142855	6
absolute	beta-estradiol 17-valerate	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	14	0.5714285714285714	6
absolute	beta-estradiol 17-valerate	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	7	0.8571428571428571	6
absolute	beta-estradiol 17-valerate	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	7	0.14285714285714285	6
absolute	beta-estradiol 17-valerate	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	14	0.5	6
absolute	beta-estradiol 17-valerate	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	14	0.5	6
absolute	beta-estradiol 17-valerate	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	7	0.8571428571428571	6
absolute	beta-estradiol 17-valerate	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	7	0.14285714285714285	6
absolute	beta-estradiol 17-valerate	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	14	0.35714285714285715	6
absolute	beta-estradiol 17-valerate	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	14	0.6428571428571429	6
absolute	beta-estradiol 17-valerate	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	beta-estradiol 17-valerate	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	9	18	0.5	6
absolute	beta-estradiol 17-valerate	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	18	0.5	6
absolute	beta-estradiol 17-valerate	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	3	0.6666666666666666	6
absolute	beta-estradiol 17-valerate	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	3	0.3333333333333333	6
absolute	beta-estradiol 17-valerate	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	18	0.5555555555555556	6
absolute	beta-estradiol 17-valerate	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	18	0.4444444444444444	6
absolute	beta-estradiol 17-valerate	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	beta-estradiol 17-valerate	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	9	18	0.5	6
absolute	beta-estradiol 17-valerate	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	18	0.5	6
absolute	beta-estradiol 17-valerate	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	beta-estradiol 17-valerate	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	9	18	0.5	6
absolute	beta-estradiol 17-valerate	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	18	0.5	6
absolute	beta-estradiol 17-valerate	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	beta-estradiol 17-valerate	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	18	0.5555555555555556	6
absolute	beta-estradiol 17-valerate	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	18	0.4444444444444444	6
absolute	beta-estradiol 17-valerate	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	beta-estradiol 17-valerate	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	18	0.5555555555555556	6
absolute	beta-estradiol 17-valerate	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	18	0.4444444444444444	6
absolute	Chlorpromazine	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	10	1	6
absolute	Chlorpromazine	5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	11	0.2727272727272727	6
absolute	Chlorpromazine	5	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	11	0.7272727272727273	6
absolute	Chlorpromazine	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	10	1	6
absolute	Chlorpromazine	5	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	11	0.2727272727272727	6
absolute	Chlorpromazine	5	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	11	0.7272727272727273	6
absolute	Chlorpromazine	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	10	1	6
absolute	Chlorpromazine	5	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	11	0.18181818181818182	6
absolute	Chlorpromazine	5	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	11	0.8181818181818182	6
absolute	Chlorpromazine	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	10	1	6
absolute	Chlorpromazine	5	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	11	0.18181818181818182	6
absolute	Chlorpromazine	5	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	11	0.8181818181818182	6
absolute	Chlorpromazine	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	10	0.8	6
absolute	Chlorpromazine	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	10	0.2	6
absolute	Chlorpromazine	5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	11	0.09090909090909091	6
absolute	Chlorpromazine	5	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	11	0.9090909090909091	6
absolute	Chlorpromazine	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	10	0.8	6
absolute	Chlorpromazine	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	10	0.2	6
absolute	Chlorpromazine	5	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	11	1	6
absolute	Chlorpromazine	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	16	21	0.7619047619047619	6
absolute	Chlorpromazine	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	21	0.23809523809523808	6
absolute	Chlorpromazine	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	16	21	0.7619047619047619	6
absolute	Chlorpromazine	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	21	0.23809523809523808	6
absolute	Chlorpromazine	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	15	21	0.7142857142857143	6
absolute	Chlorpromazine	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	21	0.2857142857142857	6
absolute	Chlorpromazine	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	15	21	0.7142857142857143	6
absolute	Chlorpromazine	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	21	0.2857142857142857	6
absolute	Chlorpromazine	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	16	21	0.7619047619047619	6
absolute	Chlorpromazine	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	21	0.23809523809523808	6
absolute	Chlorpromazine	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	16	21	0.7619047619047619	6
absolute	Chlorpromazine	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	21	0.23809523809523808	6
absolute	Ciprofloxacin	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	21	0.6666666666666666	5
absolute	Ciprofloxacin	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	21	0.3333333333333333	5
absolute	Ciprofloxacin	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	21	0.6666666666666666	5
absolute	Ciprofloxacin	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	21	0.3333333333333333	5
absolute	Ciprofloxacin	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	21	0.6666666666666666	5
absolute	Ciprofloxacin	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	21	0.3333333333333333	5
absolute	Ciprofloxacin	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	21	0.6190476190476191	5
absolute	Ciprofloxacin	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	21	0.38095238095238093	5
absolute	Ciprofloxacin	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	21	0.6190476190476191	5
absolute	Ciprofloxacin	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	21	0.38095238095238093	5
absolute	Ciprofloxacin	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	16	21	0.7619047619047619	5
absolute	Ciprofloxacin	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	21	0.23809523809523808	5
absolute	Ciprofloxacin	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	17	21	0.8095238095238095	5
absolute	Ciprofloxacin	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	21	0.19047619047619047	5
absolute	Ciprofloxacin	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	16	21	0.7619047619047619	5
absolute	Ciprofloxacin	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	21	0.23809523809523808	5
absolute	Ciprofloxacin	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	15	21	0.7142857142857143	5
absolute	Ciprofloxacin	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	21	0.2857142857142857	5
absolute	Ciprofloxacin	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	15	21	0.7142857142857143	5
absolute	Ciprofloxacin	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	21	0.2857142857142857	5
absolute	Clomiphene	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	5
absolute	Clomiphene	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	5
absolute	Clomiphene	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	5
absolute	Clomiphene	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	21	0.8095238095238095	5
absolute	Clomiphene	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	21	0.19047619047619047	5
absolute	Clomiphene	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	5
absolute	Clomiphene	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	5
absolute	Clomiphene	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	13	1	6
absolute	Clomiphene	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	8	0.375	6
absolute	Clomiphene	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	8	0.625	6
absolute	Clomiphene	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	13	1	6
absolute	Clomiphene	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	8	0.125	6
absolute	Clomiphene	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	8	0.875	6
absolute	Clomiphene	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	13	1	6
absolute	Clomiphene	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	8	0.5	6
absolute	Clomiphene	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	8	0.5	6
absolute	Clomiphene	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	13	0.9230769230769231	6
absolute	Clomiphene	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	13	0.07692307692307693	6
absolute	Clomiphene	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	8	0.125	6
absolute	Clomiphene	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	8	0.875	6
absolute	Clomiphene	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	13	0.6153846153846154	6
absolute	Clomiphene	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	5	13	0.38461538461538464	6
absolute	Clomiphene	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	8	0.25	6
absolute	Clomiphene	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	8	0.75	6
absolute	Clomiphene	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	13	0.6153846153846154	6
absolute	Clomiphene	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	5	13	0.38461538461538464	6
absolute	Clomiphene	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	8	0.25	6
absolute	Clomiphene	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	8	0.75	6
absolute	Clomiphene	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Clomiphene	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	19	20	0.95	6
absolute	Clomiphene	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	20	0.05	6
absolute	Clomiphene	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Clomiphene	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	19	20	0.95	6
absolute	Clomiphene	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	20	0.05	6
absolute	Clomiphene	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Clomiphene	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	18	20	0.9	6
absolute	Clomiphene	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	20	0.1	6
absolute	Clomiphene	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Clomiphene	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	18	20	0.9	6
absolute	Clomiphene	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	20	0.1	6
absolute	Clomiphene	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Clomiphene	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	20	20	1	6
absolute	Clomiphene	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Clomiphene	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	19	20	0.95	6
absolute	Clomiphene	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	20	0.05	6
absolute	Diacerein	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	8	1	6
absolute	Diacerein	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	13	0.23076923076923078	6
absolute	Diacerein	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	13	0.7692307692307693	6
absolute	Diacerein	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	8	1	6
absolute	Diacerein	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	13	0.15384615384615385	6
absolute	Diacerein	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	13	0.8461538461538461	6
absolute	Diacerein	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	8	1	6
absolute	Diacerein	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	13	0.07692307692307693	6
absolute	Diacerein	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	13	0.9230769230769231	6
absolute	Diacerein	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	8	1	6
absolute	Diacerein	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	13	0.15384615384615385	6
absolute	Diacerein	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	13	0.8461538461538461	6
absolute	Diacerein	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	8	1	6
absolute	Diacerein	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	13	0.07692307692307693	6
absolute	Diacerein	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	13	0.9230769230769231	6
absolute	Diacerein	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	8	0.875	6
absolute	Diacerein	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	8	0.125	6
absolute	Diacerein	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	13	0.07692307692307693	6
absolute	Diacerein	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	13	0.9230769230769231	6
absolute	Diacerein	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Diacerein	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	18	0.3333333333333333	6
absolute	Diacerein	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	18	0.6666666666666666	6
absolute	Diacerein	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Diacerein	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	18	0.2777777777777778	6
absolute	Diacerein	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	13	18	0.7222222222222222	6
absolute	Diacerein	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	3	0.6666666666666666	6
absolute	Diacerein	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	3	0.3333333333333333	6
absolute	Diacerein	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	18	0.2777777777777778	6
absolute	Diacerein	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	13	18	0.7222222222222222	6
absolute	Diacerein	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Diacerein	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	18	0.2222222222222222	6
absolute	Diacerein	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	18	0.7777777777777778	6
absolute	Diacerein	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	3	0.6666666666666666	6
absolute	Diacerein	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	3	0.3333333333333333	6
absolute	Diacerein	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	18	0.2777777777777778	6
absolute	Diacerein	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	13	18	0.7222222222222222	6
absolute	Diacerein	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	3	0.6666666666666666	6
absolute	Diacerein	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	3	0.3333333333333333	6
absolute	Diacerein	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	18	0.3888888888888889	6
absolute	Diacerein	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	18	0.6111111111111112	6
absolute	Diacerein	320	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	20	20	1	6
absolute	Diacerein	320	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	20	20	1	6
absolute	Diacerein	320	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	20	20	1	6
absolute	Diacerein	320	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	20	20	1	6
absolute	Diacerein	320	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	20	20	1	6
absolute	Diacerein	320	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	20	20	1	6
absolute	Dienestrol	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	15	1	6
absolute	Dienestrol	5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	6	0.3333333333333333	6
absolute	Dienestrol	5	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	6	0.6666666666666666	6
absolute	Dienestrol	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	15	0.9333333333333333	6
absolute	Dienestrol	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	15	0.06666666666666667	6
absolute	Dienestrol	5	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	6	0.3333333333333333	6
absolute	Dienestrol	5	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	6	0.6666666666666666	6
absolute	Dienestrol	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	15	1	6
absolute	Dienestrol	5	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	6	0.3333333333333333	6
absolute	Dienestrol	5	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	6	0.6666666666666666	6
absolute	Dienestrol	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	15	0.9333333333333333	6
absolute	Dienestrol	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	15	0.06666666666666667	6
absolute	Dienestrol	5	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	6	0.5	6
absolute	Dienestrol	5	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	6	0.5	6
absolute	Dienestrol	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	15	1	6
absolute	Dienestrol	5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	6	0.3333333333333333	6
absolute	Dienestrol	5	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	6	0.6666666666666666	6
absolute	Dienestrol	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	15	0.9333333333333333	6
absolute	Dienestrol	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	15	0.06666666666666667	6
absolute	Dienestrol	5	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	6	0.3333333333333333	6
absolute	Dienestrol	5	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	6	0.6666666666666666	6
absolute	Dienestrol	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	8	0.875	6
absolute	Dienestrol	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	8	0.125	6
absolute	Dienestrol	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	13	0.46153846153846156	6
absolute	Dienestrol	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	13	0.5384615384615384	6
absolute	Dienestrol	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	8	0.875	6
absolute	Dienestrol	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	8	0.125	6
absolute	Dienestrol	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	13	0.5384615384615384	6
absolute	Dienestrol	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	13	0.46153846153846156	6
absolute	Dienestrol	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	8	0.75	6
absolute	Dienestrol	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	8	0.25	6
absolute	Dienestrol	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	13	0.46153846153846156	6
absolute	Dienestrol	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	13	0.5384615384615384	6
absolute	Dienestrol	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	8	0.875	6
absolute	Dienestrol	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	8	0.125	6
absolute	Dienestrol	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	13	0.46153846153846156	6
absolute	Dienestrol	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	13	0.5384615384615384	6
absolute	Dienestrol	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	8	1	6
absolute	Dienestrol	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	13	0.5384615384615384	6
absolute	Dienestrol	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	13	0.46153846153846156	6
absolute	Dienestrol	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	8	1	6
absolute	Dienestrol	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	8	13	0.6153846153846154	6
absolute	Dienestrol	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	13	0.38461538461538464	6
absolute	Dienestrol	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Dienestrol	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	16	19	0.8421052631578947	6
absolute	Dienestrol	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	19	0.15789473684210525	6
absolute	Dienestrol	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Dienestrol	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	18	19	0.9473684210526315	6
absolute	Dienestrol	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	19	0.05263157894736842	6
absolute	Dienestrol	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Dienestrol	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	16	19	0.8421052631578947	6
absolute	Dienestrol	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	19	0.15789473684210525	6
absolute	Dienestrol	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	2	0.5	6
absolute	Dienestrol	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	2	0.5	6
absolute	Dienestrol	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	16	19	0.8421052631578947	6
absolute	Dienestrol	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	19	0.15789473684210525	6
absolute	Dienestrol	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	2	0.5	6
absolute	Dienestrol	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	2	0.5	6
absolute	Dienestrol	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	17	19	0.8947368421052632	6
absolute	Dienestrol	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	19	0.10526315789473684	6
absolute	Dienestrol	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	2	0.5	6
absolute	Dienestrol	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	2	0.5	6
absolute	Dienestrol	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	17	19	0.8947368421052632	6
absolute	Dienestrol	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	19	0.10526315789473684	6
absolute	Doxycycline	0.5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Doxycycline	0.5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	19	0.6842105263157895	6
absolute	Doxycycline	0.5	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	19	0.3157894736842105	6
absolute	Doxycycline	0.5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Doxycycline	0.5	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	19	0.6842105263157895	6
absolute	Doxycycline	0.5	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	19	0.3157894736842105	6
absolute	Doxycycline	0.5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Doxycycline	0.5	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	19	0.6842105263157895	6
absolute	Doxycycline	0.5	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	19	0.3157894736842105	6
absolute	Doxycycline	0.5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Doxycycline	0.5	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	19	0.6842105263157895	6
absolute	Doxycycline	0.5	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	19	0.3157894736842105	6
absolute	Doxycycline	0.5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Doxycycline	0.5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	19	0.6842105263157895	6
absolute	Doxycycline	0.5	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	19	0.3157894736842105	6
absolute	Doxycycline	0.5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Doxycycline	0.5	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	19	0.6842105263157895	6
absolute	Doxycycline	0.5	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	19	0.3157894736842105	6
absolute	Doxycycline	2.5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	21	0.6666666666666666	6
absolute	Doxycycline	2.5	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	21	0.3333333333333333	6
absolute	Doxycycline	2.5	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	21	0.6666666666666666	6
absolute	Doxycycline	2.5	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	21	0.3333333333333333	6
absolute	Doxycycline	2.5	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	21	0.6666666666666666	6
absolute	Doxycycline	2.5	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	21	0.3333333333333333	6
absolute	Doxycycline	2.5	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	15	21	0.7142857142857143	6
absolute	Doxycycline	2.5	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	21	0.2857142857142857	6
absolute	Doxycycline	2.5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	15	21	0.7142857142857143	6
absolute	Doxycycline	2.5	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	21	0.2857142857142857	6
absolute	Doxycycline	2.5	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	17	21	0.8095238095238095	6
absolute	Doxycycline	2.5	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	21	0.19047619047619047	6
absolute	Ebselen	1.25	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Ebselen	1.25	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Ebselen	1.25	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Ebselen	1.25	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Ebselen	1.25	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Ebselen	1.25	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Ebselen	1.25	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Ebselen	1.25	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Ebselen	1.25	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
absolute	Ebselen	1.25	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
absolute	Ebselen	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	16	0.875	6
absolute	Ebselen	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	16	0.125	6
absolute	Ebselen	5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	5	0.2	6
absolute	Ebselen	5	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	5	0.8	6
absolute	Ebselen	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	16	0.9375	6
absolute	Ebselen	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	16	0.0625	6
absolute	Ebselen	5	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	5	0.4	6
absolute	Ebselen	5	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	5	0.6	6
absolute	Ebselen	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	16	0.875	6
absolute	Ebselen	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	16	0.125	6
absolute	Ebselen	5	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	5	0.2	6
absolute	Ebselen	5	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	5	0.8	6
absolute	Ebselen	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	16	16	1	6
absolute	Ebselen	5	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	5	0.2	6
absolute	Ebselen	5	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	5	0.8	6
absolute	Ebselen	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	16	0.9375	6
absolute	Ebselen	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	16	0.0625	6
absolute	Ebselen	5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	5	0.6	6
absolute	Ebselen	5	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	5	0.4	6
absolute	Ebselen	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	16	0.875	6
absolute	Ebselen	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	16	0.125	6
absolute	Ebselen	5	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	5	0.6	6
absolute	Ebselen	5	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	5	0.4	6
absolute	Ebselen	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	13	0.9230769230769231	6
absolute	Ebselen	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	13	0.07692307692307693	6
absolute	Ebselen	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	8	0.625	6
absolute	Ebselen	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	8	0.375	6
absolute	Ebselen	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	13	0.7692307692307693	6
absolute	Ebselen	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	13	0.23076923076923078	6
absolute	Ebselen	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	8	0.25	6
absolute	Ebselen	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	8	0.75	6
absolute	Ebselen	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	13	0.9230769230769231	6
absolute	Ebselen	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	13	0.07692307692307693	6
absolute	Ebselen	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	8	0.625	6
absolute	Ebselen	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	8	0.375	6
absolute	Ebselen	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	13	0.9230769230769231	6
absolute	Ebselen	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	13	0.07692307692307693	6
absolute	Ebselen	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	8	0.375	6
absolute	Ebselen	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	8	0.625	6
absolute	Ebselen	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	13	0.7692307692307693	6
absolute	Ebselen	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	13	0.23076923076923078	6
absolute	Ebselen	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	8	0.5	6
absolute	Ebselen	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	8	0.5	6
absolute	Ebselen	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	13	0.6153846153846154	6
absolute	Ebselen	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	5	13	0.38461538461538464	6
absolute	Ebselen	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	8	0.875	6
absolute	Ebselen	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	8	0.125	6
absolute	Entacapone	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Entacapone	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Entacapone	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
absolute	Entacapone	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
absolute	Entacapone	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Entacapone	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Entacapone	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Entacapone	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Entacapone	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	12	1	6
absolute	Entacapone	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	9	1	6
absolute	Entacapone	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	12	1	6
absolute	Entacapone	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	9	0.1111111111111111	6
absolute	Entacapone	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	9	0.8888888888888888	6
absolute	Entacapone	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	12	0.9166666666666666	6
absolute	Entacapone	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	12	0.08333333333333333	6
absolute	Entacapone	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	9	0.1111111111111111	6
absolute	Entacapone	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	9	0.8888888888888888	6
absolute	Entacapone	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	12	1	6
absolute	Entacapone	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	9	1	6
absolute	Entacapone	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	12	1	6
absolute	Entacapone	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	9	1	6
absolute	Entacapone	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	12	0.9166666666666666	6
absolute	Entacapone	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	12	0.08333333333333333	6
absolute	Entacapone	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	9	1	6
absolute	Entacapone	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Entacapone	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	20	0.05	6
absolute	Entacapone	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	19	20	0.95	6
absolute	Entacapone	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Entacapone	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	20	0.05	6
absolute	Entacapone	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	19	20	0.95	6
absolute	Entacapone	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Entacapone	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	20	0.15	6
absolute	Entacapone	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	17	20	0.85	6
absolute	Entacapone	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Entacapone	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	20	0.1	6
absolute	Entacapone	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	18	20	0.9	6
absolute	Entacapone	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Entacapone	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	20	0.1	6
absolute	Entacapone	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	18	20	0.9	6
absolute	Entacapone	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Entacapone	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	20	0.05	6
absolute	Entacapone	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	19	20	0.95	6
absolute	Felodipine	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Felodipine	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Felodipine	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Felodipine	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Felodipine	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Felodipine	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Felodipine	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Felodipine	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Felodipine	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	5
absolute	Felodipine	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	5
absolute	Felodipine	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	10	0.6	5
absolute	Felodipine	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	10	0.4	5
absolute	Felodipine	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	5
absolute	Felodipine	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	5
absolute	Felodipine	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	10	0.6	5
absolute	Felodipine	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	10	0.4	5
absolute	Felodipine	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	5
absolute	Felodipine	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	5
absolute	Felodipine	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	10	0.5	5
absolute	Felodipine	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	10	0.5	5
absolute	Felodipine	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	5
absolute	Felodipine	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	5
absolute	Felodipine	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	10	0.5	5
absolute	Felodipine	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	10	0.5	5
absolute	Felodipine	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	5
absolute	Felodipine	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	5
absolute	Felodipine	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	10	0.6	5
absolute	Felodipine	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	10	0.4	5
absolute	Felodipine	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	3	0.6666666666666666	6
absolute	Felodipine	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	3	0.3333333333333333	6
absolute	Felodipine	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	12	18	0.6666666666666666	6
absolute	Felodipine	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	18	0.3333333333333333	6
absolute	Felodipine	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	3	0.6666666666666666	6
absolute	Felodipine	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	3	0.3333333333333333	6
absolute	Felodipine	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	18	0.7222222222222222	6
absolute	Felodipine	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	18	0.2777777777777778	6
absolute	Felodipine	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Felodipine	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	18	0.6111111111111112	6
absolute	Felodipine	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	18	0.3888888888888889	6
absolute	Felodipine	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Felodipine	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	18	0.6111111111111112	6
absolute	Felodipine	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	18	0.3888888888888889	6
absolute	Felodipine	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Felodipine	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	18	0.6111111111111112	6
absolute	Felodipine	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	18	0.3888888888888889	6
absolute	Felodipine	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Felodipine	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	12	18	0.6666666666666666	6
absolute	Felodipine	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	18	0.3333333333333333	6
absolute	Ketoconazole	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Ketoconazole	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Ketoconazole	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Ketoconazole	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Ketoconazole	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Ketoconazole	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Ketoconazole	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Ketoconazole	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Ketoconazole	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Ketoconazole	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	5
absolute	Ketoconazole	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	5
absolute	Ketoconazole	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	5
absolute	Ketoconazole	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	5
absolute	Ketoconazole	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	5
absolute	Ketoconazole	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	5
absolute	Ketoconazole	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	5
absolute	Ketoconazole	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	5
absolute	Ketoconazole	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	5
absolute	Ketoconazole	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	5
absolute	Ketoconazole	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	10	0.6	6
absolute	Ketoconazole	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	10	0.4	6
absolute	Ketoconazole	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	11	0.6363636363636364	6
absolute	Ketoconazole	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	11	0.36363636363636365	6
absolute	Ketoconazole	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	10	0.7	6
absolute	Ketoconazole	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	10	0.3	6
absolute	Ketoconazole	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	11	0.6363636363636364	6
absolute	Ketoconazole	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	11	0.36363636363636365	6
absolute	Ketoconazole	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	10	0.8	6
absolute	Ketoconazole	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	10	0.2	6
absolute	Ketoconazole	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	11	0.18181818181818182	6
absolute	Ketoconazole	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	11	0.8181818181818182	6
absolute	Ketoconazole	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	10	0.8	6
absolute	Ketoconazole	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	10	0.2	6
absolute	Ketoconazole	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	11	0.18181818181818182	6
absolute	Ketoconazole	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	11	0.8181818181818182	6
absolute	Ketoconazole	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	10	0.6	6
absolute	Ketoconazole	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	10	0.4	6
absolute	Ketoconazole	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	11	0.45454545454545453	6
absolute	Ketoconazole	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	11	0.5454545454545454	6
absolute	Ketoconazole	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	10	0.6	6
absolute	Ketoconazole	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	10	0.4	6
absolute	Ketoconazole	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	11	0.5454545454545454	6
absolute	Ketoconazole	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	11	0.45454545454545453	6
absolute	Lansoprazole	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Lansoprazole	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Lansoprazole	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
absolute	Lansoprazole	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
absolute	Lansoprazole	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Lansoprazole	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Lansoprazole	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Lansoprazole	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Lansoprazole	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Lansoprazole	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Lansoprazole	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
absolute	Lansoprazole	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
absolute	Lansoprazole	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	21	0.8571428571428571	6
absolute	Lansoprazole	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	21	0.14285714285714285	6
absolute	Lansoprazole	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Lansoprazole	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Lansoprazole	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Lansoprazole	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Lansoprazole	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Lansoprazole	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	21	0.8571428571428571	6
absolute	Lansoprazole	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	21	0.14285714285714285	6
absolute	Lansoprazole	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	14	0.8571428571428571	6
absolute	Lansoprazole	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	14	0.14285714285714285	6
absolute	Lansoprazole	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	7	0.42857142857142855	6
absolute	Lansoprazole	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	7	0.5714285714285714	6
absolute	Lansoprazole	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	14	0.9285714285714286	6
absolute	Lansoprazole	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	14	0.07142857142857142	6
absolute	Lansoprazole	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	7	0.42857142857142855	6
absolute	Lansoprazole	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	7	0.5714285714285714	6
absolute	Lansoprazole	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	14	0.9285714285714286	6
absolute	Lansoprazole	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	14	0.07142857142857142	6
absolute	Lansoprazole	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	7	0.2857142857142857	6
absolute	Lansoprazole	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	7	0.7142857142857143	6
absolute	Lansoprazole	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	14	0.9285714285714286	6
absolute	Lansoprazole	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	14	0.07142857142857142	6
absolute	Lansoprazole	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	7	0.2857142857142857	6
absolute	Lansoprazole	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	7	0.7142857142857143	6
absolute	Lansoprazole	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	14	0.8571428571428571	6
absolute	Lansoprazole	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	14	0.14285714285714285	6
absolute	Lansoprazole	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	7	0.14285714285714285	6
absolute	Lansoprazole	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	7	0.8571428571428571	6
absolute	Lansoprazole	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	14	1	6
absolute	Lansoprazole	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	7	0.2857142857142857	6
absolute	Lansoprazole	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	7	0.7142857142857143	6
absolute	Loratadine	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Loratadine	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Loratadine	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Loratadine	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Loratadine	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Loratadine	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Loratadine	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Loratadine	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Loratadine	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	19	0.9473684210526315	6
absolute	Loratadine	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	19	0.05263157894736842	6
absolute	Loratadine	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	2	1	6
absolute	Loratadine	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	19	0.8947368421052632	6
absolute	Loratadine	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	19	0.10526315789473684	6
absolute	Loratadine	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	2	1	6
absolute	Loratadine	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	19	0.9473684210526315	6
absolute	Loratadine	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	19	0.05263157894736842	6
absolute	Loratadine	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	2	1	6
absolute	Loratadine	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	19	0.9473684210526315	6
absolute	Loratadine	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	19	0.05263157894736842	6
absolute	Loratadine	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	2	0.5	6
absolute	Loratadine	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	2	0.5	6
absolute	Loratadine	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	19	1	6
absolute	Loratadine	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	2	1	6
absolute	Loratadine	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	19	1	6
absolute	Loratadine	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	2	1	6
absolute	Loratadine	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	12	0.9166666666666666	6
absolute	Loratadine	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	12	0.08333333333333333	6
absolute	Loratadine	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	9	1	6
absolute	Loratadine	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	12	0.8333333333333334	6
absolute	Loratadine	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	12	0.16666666666666666	6
absolute	Loratadine	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	9	0.1111111111111111	6
absolute	Loratadine	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	9	0.8888888888888888	6
absolute	Loratadine	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	12	0.75	6
absolute	Loratadine	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	12	0.25	6
absolute	Loratadine	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	9	0.2222222222222222	6
absolute	Loratadine	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	9	0.7777777777777778	6
absolute	Loratadine	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	12	0.75	6
absolute	Loratadine	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	12	0.25	6
absolute	Loratadine	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	9	0.2222222222222222	6
absolute	Loratadine	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	9	0.7777777777777778	6
absolute	Loratadine	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	12	0.75	6
absolute	Loratadine	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	12	0.25	6
absolute	Loratadine	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	9	0.6666666666666666	6
absolute	Loratadine	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	9	0.3333333333333333	6
absolute	Loratadine	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	12	0.75	6
absolute	Loratadine	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	12	0.25	6
absolute	Loratadine	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	9	0.6666666666666666	6
absolute	Loratadine	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	9	0.3333333333333333	6
absolute	Loxapine	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
absolute	Loxapine	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
absolute	Loxapine	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Loxapine	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Loxapine	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
absolute	Loxapine	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
absolute	Loxapine	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Loxapine	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Loxapine	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	21	0.8571428571428571	6
absolute	Loxapine	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	21	0.14285714285714285	6
absolute	Loxapine	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	21	0.8571428571428571	6
absolute	Loxapine	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	21	0.14285714285714285	6
absolute	Loxapine	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	18	0.9444444444444444	6
absolute	Loxapine	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	18	0.05555555555555555	6
absolute	Loxapine	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	3	0.3333333333333333	6
absolute	Loxapine	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	3	0.6666666666666666	6
absolute	Loxapine	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	16	18	0.8888888888888888	6
absolute	Loxapine	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	18	0.1111111111111111	6
absolute	Loxapine	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	3	0.3333333333333333	6
absolute	Loxapine	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	3	0.6666666666666666	6
absolute	Loxapine	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	16	18	0.8888888888888888	6
absolute	Loxapine	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	18	0.1111111111111111	6
absolute	Loxapine	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	3	1	6
absolute	Loxapine	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	18	1	6
absolute	Loxapine	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	3	0.3333333333333333	6
absolute	Loxapine	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	3	0.6666666666666666	6
absolute	Loxapine	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	18	0.8333333333333334	6
absolute	Loxapine	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	18	0.16666666666666666	6
absolute	Loxapine	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	3	0.6666666666666666	6
absolute	Loxapine	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	3	0.3333333333333333	6
absolute	Loxapine	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	18	1	6
absolute	Loxapine	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	3	0.6666666666666666	6
absolute	Loxapine	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	3	0.3333333333333333	6
absolute	Loxapine	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	14	0.9285714285714286	6
absolute	Loxapine	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	14	0.07142857142857142	6
absolute	Loxapine	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	7	0.5714285714285714	6
absolute	Loxapine	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	7	0.42857142857142855	6
absolute	Loxapine	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	14	1	6
absolute	Loxapine	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	7	0.5714285714285714	6
absolute	Loxapine	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	7	0.42857142857142855	6
absolute	Loxapine	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	14	0.8571428571428571	6
absolute	Loxapine	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	14	0.14285714285714285	6
absolute	Loxapine	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	7	0.5714285714285714	6
absolute	Loxapine	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	7	0.42857142857142855	6
absolute	Loxapine	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	14	0.9285714285714286	6
absolute	Loxapine	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	14	0.07142857142857142	6
absolute	Loxapine	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	7	0.42857142857142855	6
absolute	Loxapine	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	7	0.5714285714285714	6
absolute	Loxapine	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	14	0.8571428571428571	6
absolute	Loxapine	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	14	0.14285714285714285	6
absolute	Loxapine	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	7	0.42857142857142855	6
absolute	Loxapine	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	7	0.5714285714285714	6
absolute	Loxapine	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	14	0.8571428571428571	6
absolute	Loxapine	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	14	0.14285714285714285	6
absolute	Loxapine	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	7	0.5714285714285714	6
absolute	Loxapine	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	7	0.42857142857142855	6
absolute	Mecillinam	0.5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
absolute	Mecillinam	0.5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Mecillinam	0.5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	20	0.9	6
absolute	Mecillinam	0.5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	20	0.1	6
absolute	Mecillinam	0.5	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
absolute	Mecillinam	0.5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
absolute	Mecillinam	0.5	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Mecillinam	0.5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
absolute	Mecillinam	0.5	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Mecillinam	0.5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
absolute	Mecillinam	0.5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Mecillinam	0.5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	20	0.95	6
absolute	Mecillinam	0.5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	20	0.05	6
absolute	Mecillinam	0.5	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Mecillinam	2.5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	20	0.95	6
absolute	Mecillinam	2.5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	20	0.05	6
absolute	Mecillinam	2.5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Mecillinam	2.5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	20	0.95	6
absolute	Mecillinam	2.5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	20	0.05	6
absolute	Mecillinam	2.5	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Mecillinam	2.5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	20	0.9	6
absolute	Mecillinam	2.5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	20	0.1	6
absolute	Mecillinam	2.5	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Mecillinam	2.5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
absolute	Mecillinam	2.5	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Mecillinam	2.5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	20	0.95	6
absolute	Mecillinam	2.5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	20	0.05	6
absolute	Mecillinam	2.5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Mecillinam	2.5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	20	0.95	6
absolute	Mecillinam	2.5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	20	0.05	6
absolute	Mecillinam	2.5	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Mecillinam	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	17	1	6
absolute	Mecillinam	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	4	0.5	6
absolute	Mecillinam	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	4	0.5	6
absolute	Mecillinam	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	17	1	6
absolute	Mecillinam	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	4	0.75	6
absolute	Mecillinam	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	4	0.25	6
absolute	Mecillinam	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	16	17	0.9411764705882353	6
absolute	Mecillinam	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	17	0.058823529411764705	6
absolute	Mecillinam	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	4	0.75	6
absolute	Mecillinam	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	4	0.25	6
absolute	Mecillinam	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	17	1	6
absolute	Mecillinam	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	4	0.75	6
absolute	Mecillinam	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	4	0.25	6
absolute	Mecillinam	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	17	1	6
absolute	Mecillinam	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	4	0.5	6
absolute	Mecillinam	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	4	0.5	6
absolute	Mecillinam	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	17	1	6
absolute	Mecillinam	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	4	0.75	6
absolute	Mecillinam	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	4	0.25	6
absolute	Mefloquine	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	20	0.95	6
absolute	Mefloquine	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	20	0.05	6
absolute	Mefloquine	5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Mefloquine	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
absolute	Mefloquine	5	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
absolute	Mefloquine	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
absolute	Mefloquine	5	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Mefloquine	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
absolute	Mefloquine	5	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
absolute	Mefloquine	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	20	0.95	6
absolute	Mefloquine	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	20	0.05	6
absolute	Mefloquine	5	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
absolute	Mefloquine	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
absolute	Mefloquine	5	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
absolute	Mefloquine	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	6
absolute	Mefloquine	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	6
absolute	Mefloquine	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	10	0.3	6
absolute	Mefloquine	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	10	0.7	6
absolute	Mefloquine	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	11	1	6
absolute	Mefloquine	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	10	0.4	6
absolute	Mefloquine	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	10	0.6	6
absolute	Mefloquine	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	6
absolute	Mefloquine	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	6
absolute	Mefloquine	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	10	0.3	6
absolute	Mefloquine	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	10	0.7	6
absolute	Mefloquine	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	6
absolute	Mefloquine	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	6
absolute	Mefloquine	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	10	0.3	6
absolute	Mefloquine	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	10	0.7	6
absolute	Mefloquine	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	6
absolute	Mefloquine	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	6
absolute	Mefloquine	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	10	0.4	6
absolute	Mefloquine	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	10	0.6	6
absolute	Mefloquine	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	11	0.8181818181818182	6
absolute	Mefloquine	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	11	0.18181818181818182	6
absolute	Mefloquine	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	10	0.4	6
absolute	Mefloquine	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	10	0.6	6
absolute	Mefloquine	60	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Mefloquine	60	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	18	0.7777777777777778	6
absolute	Mefloquine	60	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	18	0.2222222222222222	6
absolute	Mefloquine	60	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Mefloquine	60	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	17	18	0.9444444444444444	6
absolute	Mefloquine	60	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	18	0.05555555555555555	6
absolute	Mefloquine	60	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Mefloquine	60	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	18	0.7777777777777778	6
absolute	Mefloquine	60	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	18	0.2222222222222222	6
absolute	Mefloquine	60	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Mefloquine	60	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	18	0.7777777777777778	6
absolute	Mefloquine	60	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	18	0.2222222222222222	6
absolute	Mefloquine	60	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Mefloquine	60	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	18	0.7777777777777778	6
absolute	Mefloquine	60	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	18	0.2222222222222222	6
absolute	Mefloquine	60	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	2	0.5	6
absolute	Mefloquine	60	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	2	0.5	6
absolute	Mefloquine	60	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	18	0.7777777777777778	6
absolute	Mefloquine	60	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	18	0.2222222222222222	6
absolute	Methotrexate	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	18	0.7222222222222222	6
absolute	Methotrexate	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	5	18	0.2777777777777778	6
absolute	Methotrexate	5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	3	0.6666666666666666	6
absolute	Methotrexate	5	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	3	0.3333333333333333	6
absolute	Methotrexate	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	18	0.7222222222222222	6
absolute	Methotrexate	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	5	18	0.2777777777777778	6
absolute	Methotrexate	5	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	3	0.6666666666666666	6
absolute	Methotrexate	5	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	3	0.3333333333333333	6
absolute	Methotrexate	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	18	0.7777777777777778	6
absolute	Methotrexate	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	18	0.2222222222222222	6
absolute	Methotrexate	5	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	3	0.6666666666666666	6
absolute	Methotrexate	5	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	3	0.3333333333333333	6
absolute	Methotrexate	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	18	0.7777777777777778	6
absolute	Methotrexate	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	18	0.2222222222222222	6
absolute	Methotrexate	5	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	3	0.6666666666666666	6
absolute	Methotrexate	5	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	3	0.3333333333333333	6
absolute	Methotrexate	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	18	0.6111111111111112	6
absolute	Methotrexate	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	7	18	0.3888888888888889	6
absolute	Methotrexate	5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	3	0.6666666666666666	6
absolute	Methotrexate	5	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	3	0.3333333333333333	6
absolute	Methotrexate	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	18	0.6111111111111112	6
absolute	Methotrexate	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	7	18	0.3888888888888889	6
absolute	Methotrexate	5	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	3	0.6666666666666666	6
absolute	Methotrexate	5	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	3	0.3333333333333333	6
absolute	Methotrexate	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	12	0.75	6
absolute	Methotrexate	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	12	0.25	6
absolute	Methotrexate	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	9	0.6666666666666666	6
absolute	Methotrexate	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	9	0.3333333333333333	6
absolute	Methotrexate	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	12	0.6666666666666666	6
absolute	Methotrexate	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	12	0.3333333333333333	6
absolute	Methotrexate	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	9	0.6666666666666666	6
absolute	Methotrexate	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	9	0.3333333333333333	6
absolute	Methotrexate	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	12	0.6666666666666666	6
absolute	Methotrexate	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	12	0.3333333333333333	6
absolute	Methotrexate	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	9	0.7777777777777778	6
absolute	Methotrexate	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	9	0.2222222222222222	6
absolute	Methotrexate	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	12	0.5833333333333334	6
absolute	Methotrexate	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	5	12	0.4166666666666667	6
absolute	Methotrexate	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	9	0.7777777777777778	6
absolute	Methotrexate	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	9	0.2222222222222222	6
absolute	Methotrexate	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	12	0.75	6
absolute	Methotrexate	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	12	0.25	6
absolute	Methotrexate	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	9	0.6666666666666666	6
absolute	Methotrexate	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	9	0.3333333333333333	6
absolute	Methotrexate	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	12	0.75	6
absolute	Methotrexate	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	12	0.25	6
absolute	Methotrexate	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	9	0.6666666666666666	6
absolute	Methotrexate	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	9	0.3333333333333333	6
absolute	Methotrexate	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	6	1	6
absolute	Methotrexate	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	15	0.8666666666666667	6
absolute	Methotrexate	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	15	0.13333333333333333	6
absolute	Methotrexate	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	6	1	6
absolute	Methotrexate	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	15	0.9333333333333333	6
absolute	Methotrexate	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	15	0.06666666666666667	6
absolute	Methotrexate	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	6	1	6
absolute	Methotrexate	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	15	0.9333333333333333	6
absolute	Methotrexate	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	15	0.06666666666666667	6
absolute	Methotrexate	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	6	1	6
absolute	Methotrexate	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	15	0.9333333333333333	6
absolute	Methotrexate	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	15	0.06666666666666667	6
absolute	Methotrexate	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	6	1	6
absolute	Methotrexate	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	15	0.9333333333333333	6
absolute	Methotrexate	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	15	0.06666666666666667	6
absolute	Methotrexate	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	6	1	6
absolute	Methotrexate	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	15	0.9333333333333333	6
absolute	Methotrexate	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	15	0.06666666666666667	6
absolute	Niclosamide	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Niclosamide	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	8	19	0.42105263157894735	6
absolute	Niclosamide	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	19	0.5789473684210527	6
absolute	Niclosamide	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Niclosamide	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	19	0.3157894736842105	6
absolute	Niclosamide	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	13	19	0.6842105263157895	6
absolute	Niclosamide	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Niclosamide	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	19	0.3684210526315789	6
absolute	Niclosamide	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	19	0.631578947368421	6
absolute	Niclosamide	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Niclosamide	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	8	19	0.42105263157894735	6
absolute	Niclosamide	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	19	0.5789473684210527	6
absolute	Niclosamide	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Niclosamide	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	9	19	0.47368421052631576	6
absolute	Niclosamide	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	19	0.5263157894736842	6
absolute	Niclosamide	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Niclosamide	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	19	0.3684210526315789	6
absolute	Niclosamide	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	19	0.631578947368421	6
absolute	Niclosamide	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Niclosamide	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	20	0.5	6
absolute	Niclosamide	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	20	0.5	6
absolute	Niclosamide	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Niclosamide	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	20	0.5	6
absolute	Niclosamide	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	20	0.5	6
absolute	Niclosamide	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Niclosamide	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	12	20	0.6	6
absolute	Niclosamide	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	20	0.4	6
absolute	Niclosamide	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Niclosamide	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	20	0.5	6
absolute	Niclosamide	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	20	0.5	6
absolute	Niclosamide	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Niclosamide	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	20	0.5	6
absolute	Niclosamide	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	20	0.5	6
absolute	Niclosamide	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Niclosamide	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	20	0.5	6
absolute	Niclosamide	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	20	0.5	6
absolute	Niclosamide	160	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Niclosamide	160	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	19	0.3157894736842105	6
absolute	Niclosamide	160	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	13	19	0.6842105263157895	6
absolute	Niclosamide	160	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Niclosamide	160	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	19	0.5789473684210527	6
absolute	Niclosamide	160	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	19	0.42105263157894735	6
absolute	Niclosamide	160	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Niclosamide	160	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	19	0.5263157894736842	6
absolute	Niclosamide	160	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	19	0.47368421052631576	6
absolute	Niclosamide	160	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Niclosamide	160	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	19	0.5789473684210527	6
absolute	Niclosamide	160	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	19	0.42105263157894735	6
absolute	Niclosamide	160	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Niclosamide	160	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	19	0.5263157894736842	6
absolute	Niclosamide	160	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	19	0.47368421052631576	6
absolute	Niclosamide	160	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Niclosamide	160	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	19	0.5263157894736842	6
absolute	Niclosamide	160	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	19	0.47368421052631576	6
absolute	Nifurtimox	2.5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	10	1	6
absolute	Nifurtimox	2.5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	11	0.09090909090909091	6
absolute	Nifurtimox	2.5	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	11	0.9090909090909091	6
absolute	Nifurtimox	2.5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	10	1	6
absolute	Nifurtimox	2.5	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	11	0.18181818181818182	6
absolute	Nifurtimox	2.5	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	11	0.8181818181818182	6
absolute	Nifurtimox	2.5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	10	1	6
absolute	Nifurtimox	2.5	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	11	1	6
absolute	Nifurtimox	2.5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	10	1	6
absolute	Nifurtimox	2.5	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	11	1	6
absolute	Nifurtimox	2.5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	10	1	6
absolute	Nifurtimox	2.5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	11	0.18181818181818182	6
absolute	Nifurtimox	2.5	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	11	0.8181818181818182	6
absolute	Nifurtimox	2.5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	10	1	6
absolute	Nifurtimox	2.5	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	11	0.18181818181818182	6
absolute	Nifurtimox	2.5	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	11	0.8181818181818182	6
absolute	Nifurtimox	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Nifurtimox	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	18	0.2222222222222222	6
absolute	Nifurtimox	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	18	0.7777777777777778	6
absolute	Nifurtimox	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	3	0.6666666666666666	6
absolute	Nifurtimox	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	3	0.3333333333333333	6
absolute	Nifurtimox	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	18	0.2777777777777778	6
absolute	Nifurtimox	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	13	18	0.7222222222222222	6
absolute	Nifurtimox	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Nifurtimox	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	18	18	1	6
absolute	Nifurtimox	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Nifurtimox	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	18	0.05555555555555555	6
absolute	Nifurtimox	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	17	18	0.9444444444444444	6
absolute	Nifurtimox	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	3	0.6666666666666666	6
absolute	Nifurtimox	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	3	0.3333333333333333	6
absolute	Nifurtimox	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	18	0.5555555555555556	6
absolute	Nifurtimox	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	18	0.4444444444444444	6
absolute	Nifurtimox	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	3	0.6666666666666666	6
absolute	Nifurtimox	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	3	0.3333333333333333	6
absolute	Nifurtimox	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	18	0.6111111111111112	6
absolute	Nifurtimox	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	18	0.3888888888888889	6
absolute	Nifurtimox	35	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Nifurtimox	35	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	18	0.3888888888888889	6
absolute	Nifurtimox	35	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	18	0.6111111111111112	6
absolute	Nifurtimox	35	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Nifurtimox	35	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	9	18	0.5	6
absolute	Nifurtimox	35	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	18	0.5	6
absolute	Nifurtimox	35	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Nifurtimox	35	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	18	0.1111111111111111	6
absolute	Nifurtimox	35	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	16	18	0.8888888888888888	6
absolute	Nifurtimox	35	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Nifurtimox	35	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	18	0.05555555555555555	6
absolute	Nifurtimox	35	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	17	18	0.9444444444444444	6
absolute	Nifurtimox	35	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	3	0.6666666666666666	6
absolute	Nifurtimox	35	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	3	0.3333333333333333	6
absolute	Nifurtimox	35	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	12	18	0.6666666666666666	6
absolute	Nifurtimox	35	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	18	0.3333333333333333	6
absolute	Nifurtimox	35	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	3	0.6666666666666666	6
absolute	Nifurtimox	35	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	3	0.3333333333333333	6
absolute	Nifurtimox	35	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	12	18	0.6666666666666666	6
absolute	Nifurtimox	35	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	18	0.3333333333333333	6
absolute	Olanzapine	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Olanzapine	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	21	0.8571428571428571	6
absolute	Olanzapine	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	21	0.14285714285714285	6
absolute	Olanzapine	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Olanzapine	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Olanzapine	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Olanzapine	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Olanzapine	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Olanzapine	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Olanzapine	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Olanzapine	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Olanzapine	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Olanzapine	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Olanzapine	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Olanzapine	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Olanzapine	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Olanzapine	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Olanzapine	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
absolute	Olanzapine	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
absolute	Olanzapine	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Olanzapine	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Olanzapine	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Olanzapine	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Olanzapine	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Olanzapine	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Olanzapine	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Olanzapine	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Omeprazole	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Omeprazole	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Omeprazole	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Omeprazole	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Omeprazole	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Omeprazole	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Omeprazole	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Omeprazole	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
absolute	Omeprazole	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
absolute	Omeprazole	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Omeprazole	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Omeprazole	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
absolute	Omeprazole	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
absolute	Omeprazole	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Omeprazole	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Omeprazole	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Omeprazole	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	16	18	0.8888888888888888	6
absolute	Omeprazole	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	18	0.1111111111111111	6
absolute	Omeprazole	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	3	1	6
absolute	Omeprazole	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	18	0.9444444444444444	6
absolute	Omeprazole	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	18	0.05555555555555555	6
absolute	Omeprazole	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	3	0.3333333333333333	6
absolute	Omeprazole	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	3	0.6666666666666666	6
absolute	Omeprazole	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	16	18	0.8888888888888888	6
absolute	Omeprazole	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	18	0.1111111111111111	6
absolute	Omeprazole	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	3	0.6666666666666666	6
absolute	Omeprazole	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	3	0.3333333333333333	6
absolute	Omeprazole	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	16	18	0.8888888888888888	6
absolute	Omeprazole	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	18	0.1111111111111111	6
absolute	Omeprazole	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	3	0.3333333333333333	6
absolute	Omeprazole	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	3	0.6666666666666666	6
absolute	Omeprazole	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	16	18	0.8888888888888888	6
absolute	Omeprazole	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	18	0.1111111111111111	6
absolute	Omeprazole	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	3	1	6
absolute	Omeprazole	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	18	0.9444444444444444	6
absolute	Omeprazole	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	18	0.05555555555555555	6
absolute	Omeprazole	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	3	1	6
absolute	Oxolinic acid	0.5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
absolute	Oxolinic acid	0.5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
absolute	Oxolinic acid	0.5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	21	0.8571428571428571	6
absolute	Oxolinic acid	0.5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	21	0.14285714285714285	6
absolute	Oxolinic acid	0.5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
absolute	Oxolinic acid	0.5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
absolute	Oxolinic acid	0.5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Oxolinic acid	0.5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Oxolinic acid	0.5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	21	0.8095238095238095	6
absolute	Oxolinic acid	0.5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	21	0.19047619047619047	6
absolute	Oxolinic acid	0.5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Oxolinic acid	0.5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Oxolinic acid	2.5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
absolute	Oxolinic acid	2.5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Oxolinic acid	2.5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
absolute	Oxolinic acid	2.5	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Oxolinic acid	2.5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
absolute	Oxolinic acid	2.5	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Oxolinic acid	2.5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	20	0.75	6
absolute	Oxolinic acid	2.5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	5	20	0.25	6
absolute	Oxolinic acid	2.5	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Oxolinic acid	2.5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	20	0.95	6
absolute	Oxolinic acid	2.5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	20	0.05	6
absolute	Oxolinic acid	2.5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Oxolinic acid	2.5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	20	0.85	6
absolute	Oxolinic acid	2.5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	20	0.15	6
absolute	Oxolinic acid	2.5	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
absolute	Oxolinic acid	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	18	0.8333333333333334	6
absolute	Oxolinic acid	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	18	0.16666666666666666	6
absolute	Oxolinic acid	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	3	1	6
absolute	Oxolinic acid	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	18	0.7222222222222222	6
absolute	Oxolinic acid	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	5	18	0.2777777777777778	6
absolute	Oxolinic acid	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	3	1	6
absolute	Oxolinic acid	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	18	0.8333333333333334	6
absolute	Oxolinic acid	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	18	0.16666666666666666	6
absolute	Oxolinic acid	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	3	1	6
absolute	Oxolinic acid	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	18	0.7222222222222222	6
absolute	Oxolinic acid	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	5	18	0.2777777777777778	6
absolute	Oxolinic acid	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	3	1	6
absolute	Oxolinic acid	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	16	18	0.8888888888888888	6
absolute	Oxolinic acid	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	18	0.1111111111111111	6
absolute	Oxolinic acid	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	3	1	6
absolute	Oxolinic acid	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	18	0.7777777777777778	6
absolute	Oxolinic acid	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	18	0.2222222222222222	6
absolute	Oxolinic acid	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	3	1	6
absolute	Sertindole	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Sertindole	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Sertindole	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Sertindole	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Sertindole	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Sertindole	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Sertindole	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Sertindole	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Sertindole	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	7	1	6
absolute	Sertindole	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	14	1	6
absolute	Sertindole	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	7	1	6
absolute	Sertindole	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	14	0.14285714285714285	6
absolute	Sertindole	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	14	0.8571428571428571	6
absolute	Sertindole	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	7	1	6
absolute	Sertindole	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	14	1	6
absolute	Sertindole	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	7	1	6
absolute	Sertindole	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	14	1	6
absolute	Sertindole	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	7	1	6
absolute	Sertindole	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	14	1	6
absolute	Sertindole	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	7	0.8571428571428571	6
absolute	Sertindole	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	7	0.14285714285714285	6
absolute	Sertindole	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	14	0.07142857142857142	6
absolute	Sertindole	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	13	14	0.9285714285714286	6
absolute	Sertindole	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Sertindole	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	18	0.1111111111111111	6
absolute	Sertindole	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	16	18	0.8888888888888888	6
absolute	Sertindole	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Sertindole	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	18	0.16666666666666666	6
absolute	Sertindole	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	15	18	0.8333333333333334	6
absolute	Sertindole	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Sertindole	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	18	18	1	6
absolute	Sertindole	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Sertindole	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	18	0.16666666666666666	6
absolute	Sertindole	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	15	18	0.8333333333333334	6
absolute	Sertindole	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Sertindole	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	18	18	1	6
absolute	Sertindole	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
absolute	Sertindole	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	18	0.1111111111111111	6
absolute	Sertindole	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	16	18	0.8888888888888888	6
absolute	Simvastatin	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Simvastatin	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Simvastatin	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Simvastatin	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Simvastatin	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Simvastatin	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Simvastatin	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Simvastatin	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Simvastatin	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
absolute	Simvastatin	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
absolute	Simvastatin	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
absolute	Simvastatin	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	11	1	6
absolute	Simvastatin	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	10	1	6
absolute	Simvastatin	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	11	1	6
absolute	Simvastatin	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	10	0.1	6
absolute	Simvastatin	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	10	0.9	6
absolute	Simvastatin	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	6
absolute	Simvastatin	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	6
absolute	Simvastatin	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	10	0.1	6
absolute	Simvastatin	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	10	0.9	6
absolute	Simvastatin	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	11	1	6
absolute	Simvastatin	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	10	1	6
absolute	Simvastatin	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	6
absolute	Simvastatin	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	6
absolute	Simvastatin	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	10	0.1	6
absolute	Simvastatin	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	10	0.9	6
absolute	Simvastatin	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	6
absolute	Simvastatin	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	6
absolute	Simvastatin	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	10	1	6
absolute	Simvastatin	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Simvastatin	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	19	0.2631578947368421	6
absolute	Simvastatin	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	19	0.7368421052631579	6
absolute	Simvastatin	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Simvastatin	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	19	0.5789473684210527	6
absolute	Simvastatin	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	19	0.42105263157894735	6
absolute	Simvastatin	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Simvastatin	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	19	0.3157894736842105	6
absolute	Simvastatin	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	13	19	0.6842105263157895	6
absolute	Simvastatin	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	2	0.5	6
absolute	Simvastatin	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	2	0.5	6
absolute	Simvastatin	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	19	0.5789473684210527	6
absolute	Simvastatin	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	19	0.42105263157894735	6
absolute	Simvastatin	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Simvastatin	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	19	0.6842105263157895	6
absolute	Simvastatin	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	19	0.3157894736842105	6
absolute	Simvastatin	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
absolute	Simvastatin	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	19	0.7368421052631579	6
absolute	Simvastatin	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	19	0.2631578947368421	6
absolute	Tamoxifen	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Tamoxifen	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	20	0.3	6
absolute	Tamoxifen	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	20	0.7	6
absolute	Tamoxifen	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Tamoxifen	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	20	0.3	6
absolute	Tamoxifen	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	20	0.7	6
absolute	Tamoxifen	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Tamoxifen	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	20	0.25	6
absolute	Tamoxifen	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	15	20	0.75	6
absolute	Tamoxifen	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Tamoxifen	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	20	0.3	6
absolute	Tamoxifen	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	20	0.7	6
absolute	Tamoxifen	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Tamoxifen	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	20	0.25	6
absolute	Tamoxifen	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	15	20	0.75	6
absolute	Tamoxifen	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Tamoxifen	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	20	0.2	6
absolute	Tamoxifen	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	16	20	0.8	6
absolute	Tamoxifen	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Tamoxifen	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	20	20	1	6
absolute	Tamoxifen	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Tamoxifen	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	20	20	1	6
absolute	Tamoxifen	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Tamoxifen	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	20	20	1	6
absolute	Tamoxifen	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Tamoxifen	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	20	20	1	6
absolute	Tamoxifen	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Tamoxifen	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	19	20	0.95	6
absolute	Tamoxifen	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	20	0.05	6
absolute	Tamoxifen	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
absolute	Tamoxifen	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	19	20	0.95	6
absolute	Tamoxifen	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	20	0.05	6
absolute	Tamoxifen	320	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	5
absolute	Tamoxifen	320	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	18	19	0.9473684210526315	5
absolute	Tamoxifen	320	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	19	0.05263157894736842	5
absolute	Tamoxifen	320	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	5
absolute	Tamoxifen	320	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	19	19	1	5
absolute	Tamoxifen	320	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	5
absolute	Tamoxifen	320	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	19	19	1	5
absolute	Tamoxifen	320	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	5
absolute	Tamoxifen	320	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	19	19	1	5
absolute	Tamoxifen	320	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	5
absolute	Tamoxifen	320	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	19	19	1	5
relative	Acarbose	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	20	0.85	6
relative	Acarbose	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	20	0.15	6
relative	Acarbose	5	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
relative	Acarbose	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	20	0.75	6
relative	Acarbose	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	5	20	0.25	6
relative	Acarbose	5	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
relative	Acarbose	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	16	20	0.8	6
relative	Acarbose	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	20	0.2	6
relative	Acarbose	5	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
relative	Acarbose	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	20	0.85	6
relative	Acarbose	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	20	0.15	6
relative	Acarbose	5	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
relative	Acarbose	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	20	0.85	6
relative	Acarbose	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	20	0.15	6
relative	Acarbose	5	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
relative	Acarbose	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	16	20	0.8	6
relative	Acarbose	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	20	0.2	6
relative	Acarbose	5	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
relative	Acarbose	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	16	0.6875	6
relative	Acarbose	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	5	16	0.3125	6
relative	Acarbose	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	5	0.6	6
relative	Acarbose	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	5	0.4	6
relative	Acarbose	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	16	0.75	6
relative	Acarbose	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	16	0.25	6
relative	Acarbose	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	5	0.4	6
relative	Acarbose	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	5	0.6	6
relative	Acarbose	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	16	0.8125	6
relative	Acarbose	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	16	0.1875	6
relative	Acarbose	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	5	0.2	6
relative	Acarbose	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	5	0.8	6
relative	Acarbose	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	16	0.875	6
relative	Acarbose	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	16	0.125	6
relative	Acarbose	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	5	0.4	6
relative	Acarbose	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	5	0.6	6
relative	Acarbose	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	16	0.75	6
relative	Acarbose	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	16	0.25	6
relative	Acarbose	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	5	0.4	6
relative	Acarbose	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	5	0.6	6
relative	Acarbose	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	16	0.75	6
relative	Acarbose	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	16	0.25	6
relative	Acarbose	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	5	0.4	6
relative	Acarbose	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	5	0.6	6
relative	Acarbose	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	14	0.7142857142857143	6
relative	Acarbose	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	14	0.2857142857142857	6
relative	Acarbose	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	7	0.42857142857142855	6
relative	Acarbose	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	7	0.5714285714285714	6
relative	Acarbose	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	14	0.7142857142857143	6
relative	Acarbose	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	14	0.2857142857142857	6
relative	Acarbose	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	7	0.42857142857142855	6
relative	Acarbose	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	7	0.5714285714285714	6
relative	Acarbose	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	14	0.7857142857142857	6
relative	Acarbose	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	14	0.21428571428571427	6
relative	Acarbose	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	7	0.42857142857142855	6
relative	Acarbose	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	7	0.5714285714285714	6
relative	Acarbose	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	14	0.7142857142857143	6
relative	Acarbose	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	14	0.2857142857142857	6
relative	Acarbose	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	7	0.42857142857142855	6
relative	Acarbose	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	7	0.5714285714285714	6
relative	Acarbose	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	14	0.6428571428571429	6
relative	Acarbose	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	5	14	0.35714285714285715	6
relative	Acarbose	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	7	0.5714285714285714	6
relative	Acarbose	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	7	0.42857142857142855	6
relative	Acarbose	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	14	0.7142857142857143	6
relative	Acarbose	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	14	0.2857142857142857	6
relative	Acarbose	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	7	0.5714285714285714	6
relative	Acarbose	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	7	0.42857142857142855	6
relative	Amlodipine	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	20	0.95	6
relative	Amlodipine	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	20	0.05	6
relative	Amlodipine	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Amlodipine	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
relative	Amlodipine	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
relative	Amlodipine	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
relative	Amlodipine	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Amlodipine	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	20	0.95	6
relative	Amlodipine	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	20	0.05	6
relative	Amlodipine	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Amlodipine	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
relative	Amlodipine	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
relative	Amlodipine	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	20	0.95	6
relative	Amlodipine	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	20	0.05	6
relative	Amlodipine	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
relative	Amlodipine	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	6	1	6
relative	Amlodipine	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	15	0.26666666666666666	6
relative	Amlodipine	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	15	0.7333333333333333	6
relative	Amlodipine	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	6	1	6
relative	Amlodipine	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	15	0.26666666666666666	6
relative	Amlodipine	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	15	0.7333333333333333	6
relative	Amlodipine	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	6	1	6
relative	Amlodipine	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	15	0.3333333333333333	6
relative	Amlodipine	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	15	0.6666666666666666	6
relative	Amlodipine	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	6	1	6
relative	Amlodipine	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	15	0.26666666666666666	6
relative	Amlodipine	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	15	0.7333333333333333	6
relative	Amlodipine	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	5	6	0.8333333333333334	6
relative	Amlodipine	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	6	0.16666666666666666	6
relative	Amlodipine	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	15	0.3333333333333333	6
relative	Amlodipine	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	15	0.6666666666666666	6
relative	Amlodipine	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	6	1	6
relative	Amlodipine	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	15	0.2	6
relative	Amlodipine	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	15	0.8	6
relative	Amlodipine	160	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Amlodipine	160	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	18	0.6111111111111112	6
relative	Amlodipine	160	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	18	0.3888888888888889	6
relative	Amlodipine	160	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Amlodipine	160	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	9	18	0.5	6
relative	Amlodipine	160	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	18	0.5	6
relative	Amlodipine	160	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Amlodipine	160	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	8	18	0.4444444444444444	6
relative	Amlodipine	160	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	18	0.5555555555555556	6
relative	Amlodipine	160	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Amlodipine	160	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	8	18	0.4444444444444444	6
relative	Amlodipine	160	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	18	0.5555555555555556	6
relative	Amlodipine	160	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Amlodipine	160	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	18	0.6111111111111112	6
relative	Amlodipine	160	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	18	0.3888888888888889	6
relative	Amlodipine	160	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Amlodipine	160	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	12	18	0.6666666666666666	6
relative	Amlodipine	160	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	18	0.3333333333333333	6
relative	Aprepitant	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	16	20	0.8	6
relative	Aprepitant	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	20	0.2	6
relative	Aprepitant	5	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
relative	Aprepitant	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	20	0.75	6
relative	Aprepitant	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	5	20	0.25	6
relative	Aprepitant	5	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Aprepitant	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	20	0.85	6
relative	Aprepitant	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	20	0.15	6
relative	Aprepitant	5	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Aprepitant	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	20	0.7	6
relative	Aprepitant	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	6	20	0.3	6
relative	Aprepitant	5	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Aprepitant	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	20	0.5	6
relative	Aprepitant	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	10	20	0.5	6
relative	Aprepitant	5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Aprepitant	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	20	0.3	6
relative	Aprepitant	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	14	20	0.7	6
relative	Aprepitant	5	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Aprepitant	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	11	0.8181818181818182	6
relative	Aprepitant	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	11	0.18181818181818182	6
relative	Aprepitant	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	10	0.4	6
relative	Aprepitant	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	10	0.6	6
relative	Aprepitant	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	11	0.6363636363636364	6
relative	Aprepitant	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	11	0.36363636363636365	6
relative	Aprepitant	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	10	0.4	6
relative	Aprepitant	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	10	0.6	6
relative	Aprepitant	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	11	1	6
relative	Aprepitant	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	10	0.2	6
relative	Aprepitant	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	10	0.8	6
relative	Aprepitant	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	6
relative	Aprepitant	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	6
relative	Aprepitant	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	10	0.4	6
relative	Aprepitant	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	10	0.6	6
relative	Aprepitant	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	5	11	0.45454545454545453	6
relative	Aprepitant	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	6	11	0.5454545454545454	6
relative	Aprepitant	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	10	0.5	6
relative	Aprepitant	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	10	0.5	6
relative	Aprepitant	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	11	0.5454545454545454	6
relative	Aprepitant	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	5	11	0.45454545454545453	6
relative	Aprepitant	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	10	0.4	6
relative	Aprepitant	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	10	0.6	6
relative	Aprepitant	30	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	4	0.75	6
relative	Aprepitant	30	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	4	0.25	6
relative	Aprepitant	30	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	17	0.29411764705882354	6
relative	Aprepitant	30	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	17	0.7058823529411765	6
relative	Aprepitant	30	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	4	0.75	6
relative	Aprepitant	30	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	4	0.25	6
relative	Aprepitant	30	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	17	0.35294117647058826	6
relative	Aprepitant	30	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	17	0.6470588235294118	6
relative	Aprepitant	30	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	4	0.75	6
relative	Aprepitant	30	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	4	0.25	6
relative	Aprepitant	30	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	17	0.29411764705882354	6
relative	Aprepitant	30	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	17	0.7058823529411765	6
relative	Aprepitant	30	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	4	4	1	6
relative	Aprepitant	30	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	17	0.29411764705882354	6
relative	Aprepitant	30	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	17	0.7058823529411765	6
relative	Aprepitant	30	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	4	0.5	6
relative	Aprepitant	30	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	4	0.5	6
relative	Aprepitant	30	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	9	17	0.5294117647058824	6
relative	Aprepitant	30	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	17	0.47058823529411764	6
relative	Aprepitant	30	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	4	0.25	6
relative	Aprepitant	30	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	4	0.75	6
relative	Aprepitant	30	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	8	17	0.47058823529411764	6
relative	Aprepitant	30	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	17	0.5294117647058824	6
relative	Aripiprazole	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Aripiprazole	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Aripiprazole	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Aripiprazole	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Aripiprazole	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Aripiprazole	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Aripiprazole	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Aripiprazole	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Aripiprazole	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	21	0.8095238095238095	6
relative	Aripiprazole	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	21	0.19047619047619047	6
relative	Aripiprazole	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Aripiprazole	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Aripiprazole	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Aripiprazole	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Aripiprazole	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Aripiprazole	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Aripiprazole	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Aripiprazole	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Aripiprazole	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Aripiprazole	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Aripiprazole	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	18	18	1	6
relative	Aripiprazole	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Aripiprazole	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	18	0.05555555555555555	6
relative	Aripiprazole	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	17	18	0.9444444444444444	6
relative	Aripiprazole	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Aripiprazole	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	18	18	1	6
relative	Aripiprazole	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Aripiprazole	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	18	18	1	6
relative	Aripiprazole	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Aripiprazole	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	18	18	1	6
relative	Aripiprazole	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	3	0.6666666666666666	6
relative	Aripiprazole	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	3	0.3333333333333333	6
relative	Aripiprazole	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	18	0.05555555555555555	6
relative	Aripiprazole	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	17	18	0.9444444444444444	6
relative	Azithromycin	2.5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Azithromycin	2.5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	20	0.65	6
relative	Azithromycin	2.5	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	20	0.35	6
relative	Azithromycin	2.5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Azithromycin	2.5	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	20	0.65	6
relative	Azithromycin	2.5	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	20	0.35	6
relative	Azithromycin	2.5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Azithromycin	2.5	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	20	0.65	6
relative	Azithromycin	2.5	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	20	0.35	6
relative	Azithromycin	2.5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Azithromycin	2.5	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	9	20	0.45	6
relative	Azithromycin	2.5	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	20	0.55	6
relative	Azithromycin	2.5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Azithromycin	2.5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	15	20	0.75	6
relative	Azithromycin	2.5	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	20	0.25	6
relative	Azithromycin	2.5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Azithromycin	2.5	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	20	0.7	6
relative	Azithromycin	2.5	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	20	0.3	6
relative	Azithromycin	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	21	0.6666666666666666	5
relative	Azithromycin	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	21	0.3333333333333333	5
relative	Azithromycin	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	21	0.47619047619047616	5
relative	Azithromycin	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	21	0.5238095238095238	5
relative	Azithromycin	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	8	21	0.38095238095238093	5
relative	Azithromycin	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	13	21	0.6190476190476191	5
relative	Azithromycin	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	21	0.6666666666666666	5
relative	Azithromycin	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	21	0.3333333333333333	5
relative	Azithromycin	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	21	0.6190476190476191	5
relative	Azithromycin	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	21	0.38095238095238093	5
relative	Azithromycin	50	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	21	0.6666666666666666	6
relative	Azithromycin	50	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	21	0.3333333333333333	6
relative	Azithromycin	50	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	8	21	0.38095238095238093	6
relative	Azithromycin	50	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	13	21	0.6190476190476191	6
relative	Azithromycin	50	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	21	0.5238095238095238	6
relative	Azithromycin	50	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	21	0.47619047619047616	6
relative	Azithromycin	50	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	21	0.2857142857142857	6
relative	Azithromycin	50	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	15	21	0.7142857142857143	6
relative	Azithromycin	50	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	21	0.5238095238095238	6
relative	Azithromycin	50	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	21	0.47619047619047616	6
relative	Azithromycin	50	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	12	21	0.5714285714285714	6
relative	Azithromycin	50	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	21	0.42857142857142855	6
relative	beta-estradiol 17-valerate	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	beta-estradiol 17-valerate	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	beta-estradiol 17-valerate	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	beta-estradiol 17-valerate	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	beta-estradiol 17-valerate	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	beta-estradiol 17-valerate	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	beta-estradiol 17-valerate	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	beta-estradiol 17-valerate	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	4	7	0.5714285714285714	6
relative	beta-estradiol 17-valerate	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	7	0.42857142857142855	6
relative	beta-estradiol 17-valerate	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	14	0.35714285714285715	6
relative	beta-estradiol 17-valerate	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	14	0.6428571428571429	6
relative	beta-estradiol 17-valerate	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	7	0.42857142857142855	6
relative	beta-estradiol 17-valerate	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	7	0.5714285714285714	6
relative	beta-estradiol 17-valerate	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	14	0.42857142857142855	6
relative	beta-estradiol 17-valerate	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	14	0.5714285714285714	6
relative	beta-estradiol 17-valerate	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	4	7	0.5714285714285714	6
relative	beta-estradiol 17-valerate	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	7	0.42857142857142855	6
relative	beta-estradiol 17-valerate	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	14	0.42857142857142855	6
relative	beta-estradiol 17-valerate	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	14	0.5714285714285714	6
relative	beta-estradiol 17-valerate	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	4	7	0.5714285714285714	6
relative	beta-estradiol 17-valerate	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	7	0.42857142857142855	6
relative	beta-estradiol 17-valerate	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	14	0.42857142857142855	6
relative	beta-estradiol 17-valerate	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	14	0.5714285714285714	6
relative	beta-estradiol 17-valerate	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	4	7	0.5714285714285714	6
relative	beta-estradiol 17-valerate	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	7	0.42857142857142855	6
relative	beta-estradiol 17-valerate	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	9	14	0.6428571428571429	6
relative	beta-estradiol 17-valerate	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	14	0.35714285714285715	6
relative	beta-estradiol 17-valerate	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	5	7	0.7142857142857143	6
relative	beta-estradiol 17-valerate	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	7	0.2857142857142857	6
relative	beta-estradiol 17-valerate	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	14	0.7142857142857143	6
relative	beta-estradiol 17-valerate	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	14	0.2857142857142857	6
relative	beta-estradiol 17-valerate	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	beta-estradiol 17-valerate	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	18	0.5555555555555556	6
relative	beta-estradiol 17-valerate	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	18	0.4444444444444444	6
relative	beta-estradiol 17-valerate	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	3	0.6666666666666666	6
relative	beta-estradiol 17-valerate	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	3	0.3333333333333333	6
relative	beta-estradiol 17-valerate	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	18	0.5555555555555556	6
relative	beta-estradiol 17-valerate	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	18	0.4444444444444444	6
relative	beta-estradiol 17-valerate	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	beta-estradiol 17-valerate	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	9	18	0.5	6
relative	beta-estradiol 17-valerate	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	18	0.5	6
relative	beta-estradiol 17-valerate	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	beta-estradiol 17-valerate	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	9	18	0.5	6
relative	beta-estradiol 17-valerate	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	18	0.5	6
relative	beta-estradiol 17-valerate	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	3	0.6666666666666666	6
relative	beta-estradiol 17-valerate	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	3	0.3333333333333333	6
relative	beta-estradiol 17-valerate	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	18	0.6111111111111112	6
relative	beta-estradiol 17-valerate	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	18	0.3888888888888889	6
relative	beta-estradiol 17-valerate	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	beta-estradiol 17-valerate	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	12	18	0.6666666666666666	6
relative	beta-estradiol 17-valerate	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	18	0.3333333333333333	6
relative	Chlorpromazine	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	10	1	6
relative	Chlorpromazine	5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	11	0.18181818181818182	6
relative	Chlorpromazine	5	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	11	0.8181818181818182	6
relative	Chlorpromazine	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	10	1	6
relative	Chlorpromazine	5	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	11	0.18181818181818182	6
relative	Chlorpromazine	5	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	11	0.8181818181818182	6
relative	Chlorpromazine	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	10	1	6
relative	Chlorpromazine	5	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	11	0.18181818181818182	6
relative	Chlorpromazine	5	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	11	0.8181818181818182	6
relative	Chlorpromazine	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	10	1	6
relative	Chlorpromazine	5	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	11	0.18181818181818182	6
relative	Chlorpromazine	5	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	11	0.8181818181818182	6
relative	Chlorpromazine	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	10	0.9	6
relative	Chlorpromazine	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	10	0.1	6
relative	Chlorpromazine	5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	11	0.09090909090909091	6
relative	Chlorpromazine	5	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	11	0.9090909090909091	6
relative	Chlorpromazine	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	10	0.8	6
relative	Chlorpromazine	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	10	0.2	6
relative	Chlorpromazine	5	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	11	1	6
relative	Chlorpromazine	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	21	0.19047619047619047	6
relative	Chlorpromazine	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	17	21	0.8095238095238095	6
relative	Chlorpromazine	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	21	0.3333333333333333	6
relative	Chlorpromazine	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	21	0.6666666666666666	6
relative	Chlorpromazine	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	21	0.6666666666666666	6
relative	Chlorpromazine	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	21	0.3333333333333333	6
relative	Chlorpromazine	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	21	0.6666666666666666	6
relative	Chlorpromazine	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	21	0.3333333333333333	6
relative	Chlorpromazine	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	12	21	0.5714285714285714	6
relative	Chlorpromazine	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	21	0.42857142857142855	6
relative	Chlorpromazine	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	21	0.47619047619047616	6
relative	Chlorpromazine	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	21	0.5238095238095238	6
relative	Ciprofloxacin	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	21	0.5238095238095238	5
relative	Ciprofloxacin	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	21	0.47619047619047616	5
relative	Ciprofloxacin	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	21	0.47619047619047616	5
relative	Ciprofloxacin	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	21	0.5238095238095238	5
relative	Ciprofloxacin	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	21	0.47619047619047616	5
relative	Ciprofloxacin	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	21	0.5238095238095238	5
relative	Ciprofloxacin	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	21	0.5238095238095238	5
relative	Ciprofloxacin	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	21	0.47619047619047616	5
relative	Ciprofloxacin	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	21	0.5238095238095238	5
relative	Ciprofloxacin	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	21	0.47619047619047616	5
relative	Ciprofloxacin	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	21	0.6666666666666666	5
relative	Ciprofloxacin	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	21	0.3333333333333333	5
relative	Ciprofloxacin	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	12	21	0.5714285714285714	5
relative	Ciprofloxacin	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	21	0.42857142857142855	5
relative	Ciprofloxacin	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	21	0.6190476190476191	5
relative	Ciprofloxacin	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	21	0.38095238095238093	5
relative	Ciprofloxacin	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	21	0.6666666666666666	5
relative	Ciprofloxacin	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	21	0.3333333333333333	5
relative	Ciprofloxacin	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	21	0.6190476190476191	5
relative	Ciprofloxacin	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	21	0.38095238095238093	5
relative	Clomiphene	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	21	0.8571428571428571	5
relative	Clomiphene	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	21	0.14285714285714285	5
relative	Clomiphene	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	5
relative	Clomiphene	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	5
relative	Clomiphene	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	21	0.8571428571428571	5
relative	Clomiphene	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	21	0.14285714285714285	5
relative	Clomiphene	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	5
relative	Clomiphene	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	5
relative	Clomiphene	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	13	1	6
relative	Clomiphene	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	8	0.375	6
relative	Clomiphene	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	8	0.625	6
relative	Clomiphene	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	13	1	6
relative	Clomiphene	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	8	0.125	6
relative	Clomiphene	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	8	0.875	6
relative	Clomiphene	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	13	1	6
relative	Clomiphene	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	8	0.25	6
relative	Clomiphene	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	8	0.75	6
relative	Clomiphene	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	13	0.9230769230769231	6
relative	Clomiphene	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	13	0.07692307692307693	6
relative	Clomiphene	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	8	0.125	6
relative	Clomiphene	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	8	0.875	6
relative	Clomiphene	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	13	0.8461538461538461	6
relative	Clomiphene	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	13	0.15384615384615385	6
relative	Clomiphene	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	8	0.125	6
relative	Clomiphene	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	8	0.875	6
relative	Clomiphene	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	13	0.8461538461538461	6
relative	Clomiphene	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	13	0.15384615384615385	6
relative	Clomiphene	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	8	0.25	6
relative	Clomiphene	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	8	0.75	6
relative	Clomiphene	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Clomiphene	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	20	0.1	6
relative	Clomiphene	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	18	20	0.9	6
relative	Clomiphene	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Clomiphene	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	20	0.1	6
relative	Clomiphene	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	18	20	0.9	6
relative	Clomiphene	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Clomiphene	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	8	20	0.4	6
relative	Clomiphene	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	20	0.6	6
relative	Clomiphene	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Clomiphene	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	20	0.35	6
relative	Clomiphene	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	13	20	0.65	6
relative	Clomiphene	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Clomiphene	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	20	0.15	6
relative	Clomiphene	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	17	20	0.85	6
relative	Clomiphene	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Clomiphene	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	20	0.35	6
relative	Clomiphene	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	13	20	0.65	6
relative	Diacerein	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	8	1	6
relative	Diacerein	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	13	0.15384615384615385	6
relative	Diacerein	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	13	0.8461538461538461	6
relative	Diacerein	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	8	1	6
relative	Diacerein	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	13	0.07692307692307693	6
relative	Diacerein	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	13	0.9230769230769231	6
relative	Diacerein	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	8	1	6
relative	Diacerein	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	13	0.07692307692307693	6
relative	Diacerein	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	13	0.9230769230769231	6
relative	Diacerein	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	8	1	6
relative	Diacerein	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	13	0.15384615384615385	6
relative	Diacerein	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	13	0.8461538461538461	6
relative	Diacerein	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	8	0.875	6
relative	Diacerein	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	8	0.125	6
relative	Diacerein	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	13	0.15384615384615385	6
relative	Diacerein	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	13	0.8461538461538461	6
relative	Diacerein	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	8	0.875	6
relative	Diacerein	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	8	0.125	6
relative	Diacerein	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	13	0.07692307692307693	6
relative	Diacerein	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	13	0.9230769230769231	6
relative	Diacerein	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Diacerein	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	18	0.2222222222222222	6
relative	Diacerein	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	18	0.7777777777777778	6
relative	Diacerein	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Diacerein	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	18	0.2222222222222222	6
relative	Diacerein	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	18	0.7777777777777778	6
relative	Diacerein	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Diacerein	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	18	0.2222222222222222	6
relative	Diacerein	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	18	0.7777777777777778	6
relative	Diacerein	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Diacerein	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	18	0.16666666666666666	6
relative	Diacerein	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	15	18	0.8333333333333334	6
relative	Diacerein	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Diacerein	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	18	0.2777777777777778	6
relative	Diacerein	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	13	18	0.7222222222222222	6
relative	Diacerein	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	3	0.6666666666666666	6
relative	Diacerein	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	3	0.3333333333333333	6
relative	Diacerein	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	18	0.2777777777777778	6
relative	Diacerein	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	13	18	0.7222222222222222	6
relative	Diacerein	320	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	20	0.35	6
relative	Diacerein	320	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	13	20	0.65	6
relative	Diacerein	320	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	20	0.55	6
relative	Diacerein	320	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	20	0.45	6
relative	Diacerein	320	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	8	20	0.4	6
relative	Diacerein	320	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	20	0.6	6
relative	Diacerein	320	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	8	20	0.4	6
relative	Diacerein	320	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	20	0.6	6
relative	Diacerein	320	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	20	0.35	6
relative	Diacerein	320	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	13	20	0.65	6
relative	Diacerein	320	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	9	20	0.45	6
relative	Diacerein	320	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	20	0.55	6
relative	Dienestrol	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	15	1	6
relative	Dienestrol	5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	6	0.3333333333333333	6
relative	Dienestrol	5	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	6	0.6666666666666666	6
relative	Dienestrol	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	15	0.9333333333333333	6
relative	Dienestrol	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	15	0.06666666666666667	6
relative	Dienestrol	5	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	6	0.3333333333333333	6
relative	Dienestrol	5	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	6	0.6666666666666666	6
relative	Dienestrol	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	15	1	6
relative	Dienestrol	5	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	6	0.3333333333333333	6
relative	Dienestrol	5	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	6	0.6666666666666666	6
relative	Dienestrol	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	15	0.9333333333333333	6
relative	Dienestrol	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	15	0.06666666666666667	6
relative	Dienestrol	5	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	6	0.5	6
relative	Dienestrol	5	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	6	0.5	6
relative	Dienestrol	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	15	1	6
relative	Dienestrol	5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	6	0.3333333333333333	6
relative	Dienestrol	5	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	6	0.6666666666666666	6
relative	Dienestrol	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	15	0.9333333333333333	6
relative	Dienestrol	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	15	0.06666666666666667	6
relative	Dienestrol	5	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	6	0.3333333333333333	6
relative	Dienestrol	5	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	6	0.6666666666666666	6
relative	Dienestrol	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	8	1	6
relative	Dienestrol	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	13	0.46153846153846156	6
relative	Dienestrol	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	13	0.5384615384615384	6
relative	Dienestrol	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	8	0.875	6
relative	Dienestrol	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	8	0.125	6
relative	Dienestrol	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	13	0.5384615384615384	6
relative	Dienestrol	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	13	0.46153846153846156	6
relative	Dienestrol	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	8	1	6
relative	Dienestrol	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	13	0.46153846153846156	6
relative	Dienestrol	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	13	0.5384615384615384	6
relative	Dienestrol	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	8	1	6
relative	Dienestrol	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	13	0.38461538461538464	6
relative	Dienestrol	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	13	0.6153846153846154	6
relative	Dienestrol	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	8	1	6
relative	Dienestrol	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	13	0.46153846153846156	6
relative	Dienestrol	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	13	0.5384615384615384	6
relative	Dienestrol	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	8	1	6
relative	Dienestrol	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	13	0.46153846153846156	6
relative	Dienestrol	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	13	0.5384615384615384	6
relative	Dienestrol	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Dienestrol	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	19	0.3684210526315789	6
relative	Dienestrol	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	19	0.631578947368421	6
relative	Dienestrol	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Dienestrol	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	19	0.5789473684210527	6
relative	Dienestrol	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	19	0.42105263157894735	6
relative	Dienestrol	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Dienestrol	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	19	0.3684210526315789	6
relative	Dienestrol	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	19	0.631578947368421	6
relative	Dienestrol	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Dienestrol	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	19	0.5789473684210527	6
relative	Dienestrol	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	19	0.42105263157894735	6
relative	Dienestrol	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Dienestrol	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	12	19	0.631578947368421	6
relative	Dienestrol	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	19	0.3684210526315789	6
relative	Dienestrol	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Dienestrol	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	19	0.6842105263157895	6
relative	Dienestrol	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	19	0.3157894736842105	6
relative	Doxycycline	0.5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Doxycycline	0.5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	19	0.6842105263157895	6
relative	Doxycycline	0.5	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	19	0.3157894736842105	6
relative	Doxycycline	0.5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Doxycycline	0.5	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	19	0.6842105263157895	6
relative	Doxycycline	0.5	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	19	0.3157894736842105	6
relative	Doxycycline	0.5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Doxycycline	0.5	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	12	19	0.631578947368421	6
relative	Doxycycline	0.5	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	19	0.3684210526315789	6
relative	Doxycycline	0.5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Doxycycline	0.5	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	12	19	0.631578947368421	6
relative	Doxycycline	0.5	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	19	0.3684210526315789	6
relative	Doxycycline	0.5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Doxycycline	0.5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	19	0.6842105263157895	6
relative	Doxycycline	0.5	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	19	0.3157894736842105	6
relative	Doxycycline	0.5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Doxycycline	0.5	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	19	0.6842105263157895	6
relative	Doxycycline	0.5	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	19	0.3157894736842105	6
relative	Doxycycline	2.5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	16	21	0.7619047619047619	6
relative	Doxycycline	2.5	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	21	0.23809523809523808	6
relative	Doxycycline	2.5	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	21	0.6666666666666666	6
relative	Doxycycline	2.5	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	21	0.3333333333333333	6
relative	Doxycycline	2.5	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	21	0.6666666666666666	6
relative	Doxycycline	2.5	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	21	0.3333333333333333	6
relative	Doxycycline	2.5	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	21	0.6666666666666666	6
relative	Doxycycline	2.5	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	21	0.3333333333333333	6
relative	Doxycycline	2.5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	21	0.6190476190476191	6
relative	Doxycycline	2.5	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	21	0.38095238095238093	6
relative	Doxycycline	2.5	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	21	0.6190476190476191	6
relative	Doxycycline	2.5	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	21	0.38095238095238093	6
relative	Ebselen	1.25	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Ebselen	1.25	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Ebselen	1.25	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Ebselen	1.25	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Ebselen	1.25	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Ebselen	1.25	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Ebselen	1.25	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Ebselen	1.25	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Ebselen	1.25	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
relative	Ebselen	1.25	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
relative	Ebselen	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	16	0.8125	6
relative	Ebselen	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	16	0.1875	6
relative	Ebselen	5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	5	0.2	6
relative	Ebselen	5	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	5	0.8	6
relative	Ebselen	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	16	0.9375	6
relative	Ebselen	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	16	0.0625	6
relative	Ebselen	5	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	5	0.2	6
relative	Ebselen	5	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	5	0.8	6
relative	Ebselen	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	16	0.9375	6
relative	Ebselen	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	16	0.0625	6
relative	Ebselen	5	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	5	0.2	6
relative	Ebselen	5	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	5	0.8	6
relative	Ebselen	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	16	16	1	6
relative	Ebselen	5	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	5	0.2	6
relative	Ebselen	5	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	5	0.8	6
relative	Ebselen	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	16	0.9375	6
relative	Ebselen	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	16	0.0625	6
relative	Ebselen	5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	5	0.6	6
relative	Ebselen	5	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	5	0.4	6
relative	Ebselen	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	16	0.8125	6
relative	Ebselen	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	16	0.1875	6
relative	Ebselen	5	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	5	0.6	6
relative	Ebselen	5	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	5	0.4	6
relative	Ebselen	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	13	0.9230769230769231	6
relative	Ebselen	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	13	0.07692307692307693	6
relative	Ebselen	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	8	0.5	6
relative	Ebselen	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	8	0.5	6
relative	Ebselen	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	13	0.9230769230769231	6
relative	Ebselen	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	13	0.07692307692307693	6
relative	Ebselen	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	8	0.125	6
relative	Ebselen	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	8	0.875	6
relative	Ebselen	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	13	0.9230769230769231	6
relative	Ebselen	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	13	0.07692307692307693	6
relative	Ebselen	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	8	0.625	6
relative	Ebselen	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	8	0.375	6
relative	Ebselen	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	13	0.9230769230769231	6
relative	Ebselen	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	13	0.07692307692307693	6
relative	Ebselen	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	8	0.625	6
relative	Ebselen	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	8	0.375	6
relative	Ebselen	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	13	0.6153846153846154	6
relative	Ebselen	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	5	13	0.38461538461538464	6
relative	Ebselen	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	8	0.875	6
relative	Ebselen	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	8	0.125	6
relative	Ebselen	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	13	0.5384615384615384	6
relative	Ebselen	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	6	13	0.46153846153846156	6
relative	Ebselen	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	8	0.875	6
relative	Ebselen	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	8	0.125	6
relative	Entacapone	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Entacapone	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Entacapone	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
relative	Entacapone	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
relative	Entacapone	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Entacapone	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Entacapone	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Entacapone	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Entacapone	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Entacapone	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	12	1	6
relative	Entacapone	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	9	1	6
relative	Entacapone	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	12	1	6
relative	Entacapone	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	9	0.2222222222222222	6
relative	Entacapone	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	9	0.7777777777777778	6
relative	Entacapone	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	12	0.9166666666666666	6
relative	Entacapone	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	12	0.08333333333333333	6
relative	Entacapone	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	9	0.1111111111111111	6
relative	Entacapone	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	9	0.8888888888888888	6
relative	Entacapone	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	12	1	6
relative	Entacapone	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	9	1	6
relative	Entacapone	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	12	1	6
relative	Entacapone	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	9	1	6
relative	Entacapone	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	12	0.9166666666666666	6
relative	Entacapone	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	12	0.08333333333333333	6
relative	Entacapone	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	9	1	6
relative	Entacapone	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Entacapone	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	20	0.05	6
relative	Entacapone	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	19	20	0.95	6
relative	Entacapone	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Entacapone	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	20	0.1	6
relative	Entacapone	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	18	20	0.9	6
relative	Entacapone	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Entacapone	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	20	0.15	6
relative	Entacapone	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	17	20	0.85	6
relative	Entacapone	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Entacapone	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	20	0.1	6
relative	Entacapone	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	18	20	0.9	6
relative	Entacapone	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Entacapone	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	20	0.1	6
relative	Entacapone	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	18	20	0.9	6
relative	Entacapone	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Entacapone	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	20	0.05	6
relative	Entacapone	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	19	20	0.95	6
relative	Felodipine	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Felodipine	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Felodipine	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Felodipine	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Felodipine	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Felodipine	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Felodipine	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Felodipine	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Felodipine	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Felodipine	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	11	0.8181818181818182	5
relative	Felodipine	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	11	0.18181818181818182	5
relative	Felodipine	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	10	0.6	5
relative	Felodipine	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	10	0.4	5
relative	Felodipine	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	5
relative	Felodipine	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	5
relative	Felodipine	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	10	0.7	5
relative	Felodipine	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	10	0.3	5
relative	Felodipine	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	5
relative	Felodipine	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	5
relative	Felodipine	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	10	0.5	5
relative	Felodipine	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	10	0.5	5
relative	Felodipine	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	11	0.8181818181818182	5
relative	Felodipine	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	11	0.18181818181818182	5
relative	Felodipine	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	10	0.5	5
relative	Felodipine	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	10	0.5	5
relative	Felodipine	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	5
relative	Felodipine	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	5
relative	Felodipine	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	10	0.6	5
relative	Felodipine	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	10	0.4	5
relative	Felodipine	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Felodipine	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	12	18	0.6666666666666666	6
relative	Felodipine	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	18	0.3333333333333333	6
relative	Felodipine	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Felodipine	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	9	18	0.5	6
relative	Felodipine	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	18	0.5	6
relative	Felodipine	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Felodipine	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	18	0.6111111111111112	6
relative	Felodipine	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	18	0.3888888888888889	6
relative	Felodipine	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Felodipine	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	18	0.5555555555555556	6
relative	Felodipine	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	18	0.4444444444444444	6
relative	Felodipine	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Felodipine	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	18	0.6111111111111112	6
relative	Felodipine	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	18	0.3888888888888889	6
relative	Felodipine	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Felodipine	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	18	0.6111111111111112	6
relative	Felodipine	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	18	0.3888888888888889	6
relative	Ketoconazole	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Ketoconazole	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Ketoconazole	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Ketoconazole	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Ketoconazole	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Ketoconazole	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Ketoconazole	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Ketoconazole	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
relative	Ketoconazole	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
relative	Ketoconazole	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	5
relative	Ketoconazole	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	5
relative	Ketoconazole	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	5
relative	Ketoconazole	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	5
relative	Ketoconazole	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	5
relative	Ketoconazole	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	5
relative	Ketoconazole	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	5
relative	Ketoconazole	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	5
relative	Ketoconazole	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	16	21	0.7619047619047619	5
relative	Ketoconazole	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	5	21	0.23809523809523808	5
relative	Ketoconazole	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	10	0.9	6
relative	Ketoconazole	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	10	0.1	6
relative	Ketoconazole	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	11	0.09090909090909091	6
relative	Ketoconazole	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	11	0.9090909090909091	6
relative	Ketoconazole	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	10	0.7	6
relative	Ketoconazole	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	10	0.3	6
relative	Ketoconazole	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	11	0.2727272727272727	6
relative	Ketoconazole	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	11	0.7272727272727273	6
relative	Ketoconazole	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	10	0.8	6
relative	Ketoconazole	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	10	0.2	6
relative	Ketoconazole	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	11	0.09090909090909091	6
relative	Ketoconazole	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	11	0.9090909090909091	6
relative	Ketoconazole	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	10	0.9	6
relative	Ketoconazole	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	10	0.1	6
relative	Ketoconazole	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	11	1	6
relative	Ketoconazole	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	5	10	0.5	6
relative	Ketoconazole	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	5	10	0.5	6
relative	Ketoconazole	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	11	0.5454545454545454	6
relative	Ketoconazole	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	11	0.45454545454545453	6
relative	Ketoconazole	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	10	0.6	6
relative	Ketoconazole	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	10	0.4	6
relative	Ketoconazole	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	11	0.45454545454545453	6
relative	Ketoconazole	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	11	0.5454545454545454	6
relative	Lansoprazole	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Lansoprazole	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
relative	Lansoprazole	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
relative	Lansoprazole	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Lansoprazole	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Lansoprazole	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Lansoprazole	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Lansoprazole	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
relative	Lansoprazole	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
relative	Lansoprazole	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
relative	Lansoprazole	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
relative	Lansoprazole	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	21	0.8571428571428571	6
relative	Lansoprazole	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	21	0.14285714285714285	6
relative	Lansoprazole	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Lansoprazole	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Lansoprazole	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Lansoprazole	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Lansoprazole	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Lansoprazole	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	21	0.6190476190476191	6
relative	Lansoprazole	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	8	21	0.38095238095238093	6
relative	Lansoprazole	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	14	1	6
relative	Lansoprazole	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	7	0.2857142857142857	6
relative	Lansoprazole	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	7	0.7142857142857143	6
relative	Lansoprazole	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	14	0.9285714285714286	6
relative	Lansoprazole	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	14	0.07142857142857142	6
relative	Lansoprazole	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	7	0.42857142857142855	6
relative	Lansoprazole	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	7	0.5714285714285714	6
relative	Lansoprazole	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	14	1	6
relative	Lansoprazole	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	7	0.14285714285714285	6
relative	Lansoprazole	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	7	0.8571428571428571	6
relative	Lansoprazole	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	14	0.9285714285714286	6
relative	Lansoprazole	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	14	0.07142857142857142	6
relative	Lansoprazole	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	7	0.2857142857142857	6
relative	Lansoprazole	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	7	0.7142857142857143	6
relative	Lansoprazole	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	14	0.8571428571428571	6
relative	Lansoprazole	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	14	0.14285714285714285	6
relative	Lansoprazole	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	7	0.2857142857142857	6
relative	Lansoprazole	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	7	0.7142857142857143	6
relative	Lansoprazole	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	14	1	6
relative	Lansoprazole	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	7	0.2857142857142857	6
relative	Lansoprazole	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	7	0.7142857142857143	6
relative	Loratadine	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Loratadine	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Loratadine	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Loratadine	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Loratadine	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Loratadine	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Loratadine	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Loratadine	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Loratadine	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	19	0.9473684210526315	6
relative	Loratadine	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	19	0.05263157894736842	6
relative	Loratadine	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	2	1	6
relative	Loratadine	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	19	0.8947368421052632	6
relative	Loratadine	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	19	0.10526315789473684	6
relative	Loratadine	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	2	1	6
relative	Loratadine	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	19	0.9473684210526315	6
relative	Loratadine	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	19	0.05263157894736842	6
relative	Loratadine	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	2	1	6
relative	Loratadine	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	19	0.8947368421052632	6
relative	Loratadine	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	19	0.10526315789473684	6
relative	Loratadine	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	2	0.5	6
relative	Loratadine	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	2	0.5	6
relative	Loratadine	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	19	1	6
relative	Loratadine	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	2	1	6
relative	Loratadine	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	19	1	6
relative	Loratadine	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	2	1	6
relative	Loratadine	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	12	0.9166666666666666	6
relative	Loratadine	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	12	0.08333333333333333	6
relative	Loratadine	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	9	0.1111111111111111	6
relative	Loratadine	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	9	0.8888888888888888	6
relative	Loratadine	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	12	0.9166666666666666	6
relative	Loratadine	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	12	0.08333333333333333	6
relative	Loratadine	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	9	0.1111111111111111	6
relative	Loratadine	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	9	0.8888888888888888	6
relative	Loratadine	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	12	0.75	6
relative	Loratadine	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	12	0.25	6
relative	Loratadine	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	9	0.3333333333333333	6
relative	Loratadine	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	9	0.6666666666666666	6
relative	Loratadine	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	12	0.75	6
relative	Loratadine	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	12	0.25	6
relative	Loratadine	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	9	0.3333333333333333	6
relative	Loratadine	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	9	0.6666666666666666	6
relative	Loratadine	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	12	0.75	6
relative	Loratadine	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	12	0.25	6
relative	Loratadine	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	9	0.7777777777777778	6
relative	Loratadine	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	9	0.2222222222222222	6
relative	Loratadine	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	12	0.6666666666666666	6
relative	Loratadine	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	12	0.3333333333333333	6
relative	Loratadine	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	9	0.7777777777777778	6
relative	Loratadine	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	9	0.2222222222222222	6
relative	Loxapine	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
relative	Loxapine	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
relative	Loxapine	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Loxapine	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Loxapine	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Loxapine	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Loxapine	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Loxapine	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Loxapine	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Loxapine	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Loxapine	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
relative	Loxapine	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
relative	Loxapine	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	18	0.9444444444444444	6
relative	Loxapine	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	18	0.05555555555555555	6
relative	Loxapine	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	3	0.3333333333333333	6
relative	Loxapine	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	3	0.6666666666666666	6
relative	Loxapine	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	16	18	0.8888888888888888	6
relative	Loxapine	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	18	0.1111111111111111	6
relative	Loxapine	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	3	0.3333333333333333	6
relative	Loxapine	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	3	0.6666666666666666	6
relative	Loxapine	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	18	1	6
relative	Loxapine	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	3	0.3333333333333333	6
relative	Loxapine	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	3	0.6666666666666666	6
relative	Loxapine	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	18	1	6
relative	Loxapine	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	3	0.3333333333333333	6
relative	Loxapine	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	3	0.6666666666666666	6
relative	Loxapine	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	16	18	0.8888888888888888	6
relative	Loxapine	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	18	0.1111111111111111	6
relative	Loxapine	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	3	0.3333333333333333	6
relative	Loxapine	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	3	0.6666666666666666	6
relative	Loxapine	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	18	1	6
relative	Loxapine	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	3	0.3333333333333333	6
relative	Loxapine	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	3	0.6666666666666666	6
relative	Loxapine	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	14	0.9285714285714286	6
relative	Loxapine	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	14	0.07142857142857142	6
relative	Loxapine	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	7	0.42857142857142855	6
relative	Loxapine	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	7	0.5714285714285714	6
relative	Loxapine	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	14	1	6
relative	Loxapine	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	7	0.2857142857142857	6
relative	Loxapine	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	7	0.7142857142857143	6
relative	Loxapine	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	14	0.9285714285714286	6
relative	Loxapine	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	14	0.07142857142857142	6
relative	Loxapine	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	7	0.42857142857142855	6
relative	Loxapine	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	7	0.5714285714285714	6
relative	Loxapine	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	14	1	6
relative	Loxapine	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	7	0.42857142857142855	6
relative	Loxapine	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	7	0.5714285714285714	6
relative	Loxapine	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	14	1	6
relative	Loxapine	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	7	0.42857142857142855	6
relative	Loxapine	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	7	0.5714285714285714	6
relative	Loxapine	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	14	1	6
relative	Loxapine	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	7	0.42857142857142855	6
relative	Loxapine	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	7	0.5714285714285714	6
relative	Mecillinam	0.5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
relative	Mecillinam	0.5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Mecillinam	0.5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	20	0.7	6
relative	Mecillinam	0.5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	6	20	0.3	6
relative	Mecillinam	0.5	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
relative	Mecillinam	0.5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
relative	Mecillinam	0.5	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Mecillinam	0.5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
relative	Mecillinam	0.5	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Mecillinam	0.5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	20	0.9	6
relative	Mecillinam	0.5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	20	0.1	6
relative	Mecillinam	0.5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Mecillinam	0.5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	20	0.95	6
relative	Mecillinam	0.5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	20	0.05	6
relative	Mecillinam	0.5	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Mecillinam	2.5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	20	0.95	6
relative	Mecillinam	2.5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	20	0.05	6
relative	Mecillinam	2.5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Mecillinam	2.5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	20	0.95	6
relative	Mecillinam	2.5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	20	0.05	6
relative	Mecillinam	2.5	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Mecillinam	2.5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
relative	Mecillinam	2.5	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Mecillinam	2.5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
relative	Mecillinam	2.5	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Mecillinam	2.5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	20	0.9	6
relative	Mecillinam	2.5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	20	0.1	6
relative	Mecillinam	2.5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Mecillinam	2.5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	20	0.85	6
relative	Mecillinam	2.5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	20	0.15	6
relative	Mecillinam	2.5	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Mecillinam	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	17	1	6
relative	Mecillinam	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	4	0.5	6
relative	Mecillinam	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	4	0.5	6
relative	Mecillinam	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	17	1	6
relative	Mecillinam	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	4	0.75	6
relative	Mecillinam	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	4	0.25	6
relative	Mecillinam	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	16	17	0.9411764705882353	6
relative	Mecillinam	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	17	0.058823529411764705	6
relative	Mecillinam	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	4	0.5	6
relative	Mecillinam	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	4	0.5	6
relative	Mecillinam	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	17	1	6
relative	Mecillinam	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	4	0.5	6
relative	Mecillinam	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	4	0.5	6
relative	Mecillinam	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	17	1	6
relative	Mecillinam	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	4	0.5	6
relative	Mecillinam	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	4	0.5	6
relative	Mecillinam	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	17	1	6
relative	Mecillinam	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	4	0.75	6
relative	Mecillinam	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	4	0.25	6
relative	Mefloquine	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	20	0.85	6
relative	Mefloquine	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	20	0.15	6
relative	Mefloquine	5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Mefloquine	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	20	0.9	6
relative	Mefloquine	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	20	0.1	6
relative	Mefloquine	5	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
relative	Mefloquine	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
relative	Mefloquine	5	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
relative	Mefloquine	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
relative	Mefloquine	5	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
relative	Mefloquine	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	20	0.95	6
relative	Mefloquine	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	20	0.05	6
relative	Mefloquine	5	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
relative	Mefloquine	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
relative	Mefloquine	5	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	1	1	6
relative	Mefloquine	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	6
relative	Mefloquine	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	6
relative	Mefloquine	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	10	0.5	6
relative	Mefloquine	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	10	0.5	6
relative	Mefloquine	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	11	1	6
relative	Mefloquine	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	10	0.2	6
relative	Mefloquine	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	10	0.8	6
relative	Mefloquine	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	6
relative	Mefloquine	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	6
relative	Mefloquine	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	10	0.3	6
relative	Mefloquine	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	10	0.7	6
relative	Mefloquine	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	6
relative	Mefloquine	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	6
relative	Mefloquine	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	10	0.3	6
relative	Mefloquine	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	10	0.7	6
relative	Mefloquine	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	6
relative	Mefloquine	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	6
relative	Mefloquine	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	10	0.4	6
relative	Mefloquine	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	10	0.6	6
relative	Mefloquine	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	11	0.8181818181818182	6
relative	Mefloquine	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	11	0.18181818181818182	6
relative	Mefloquine	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	10	0.5	6
relative	Mefloquine	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	10	0.5	6
relative	Mefloquine	60	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Mefloquine	60	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	18	0.2222222222222222	6
relative	Mefloquine	60	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	18	0.7777777777777778	6
relative	Mefloquine	60	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Mefloquine	60	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	18	0.2222222222222222	6
relative	Mefloquine	60	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	18	0.7777777777777778	6
relative	Mefloquine	60	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Mefloquine	60	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	18	0.6111111111111112	6
relative	Mefloquine	60	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	18	0.3888888888888889	6
relative	Mefloquine	60	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Mefloquine	60	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	18	0.7222222222222222	6
relative	Mefloquine	60	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	18	0.2777777777777778	6
relative	Mefloquine	60	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Mefloquine	60	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	18	0.3888888888888889	6
relative	Mefloquine	60	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	18	0.6111111111111112	6
relative	Mefloquine	60	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Mefloquine	60	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	18	0.7222222222222222	6
relative	Mefloquine	60	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	18	0.2777777777777778	6
relative	Methotrexate	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	18	0.7777777777777778	6
relative	Methotrexate	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	18	0.2222222222222222	6
relative	Methotrexate	5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	3	0.6666666666666666	6
relative	Methotrexate	5	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	3	0.3333333333333333	6
relative	Methotrexate	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	18	0.7777777777777778	6
relative	Methotrexate	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	18	0.2222222222222222	6
relative	Methotrexate	5	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	3	0.6666666666666666	6
relative	Methotrexate	5	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	3	0.3333333333333333	6
relative	Methotrexate	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	16	18	0.8888888888888888	6
relative	Methotrexate	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	18	0.1111111111111111	6
relative	Methotrexate	5	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	3	0.6666666666666666	6
relative	Methotrexate	5	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	3	0.3333333333333333	6
relative	Methotrexate	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	18	0.8333333333333334	6
relative	Methotrexate	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	18	0.16666666666666666	6
relative	Methotrexate	5	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	3	0.6666666666666666	6
relative	Methotrexate	5	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	3	0.3333333333333333	6
relative	Methotrexate	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	18	0.6666666666666666	6
relative	Methotrexate	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	6	18	0.3333333333333333	6
relative	Methotrexate	5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	3	0.6666666666666666	6
relative	Methotrexate	5	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	3	0.3333333333333333	6
relative	Methotrexate	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	18	0.8333333333333334	6
relative	Methotrexate	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	18	0.16666666666666666	6
relative	Methotrexate	5	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	3	0.6666666666666666	6
relative	Methotrexate	5	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	3	0.3333333333333333	6
relative	Methotrexate	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	12	0.75	6
relative	Methotrexate	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	12	0.25	6
relative	Methotrexate	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	9	0.5555555555555556	6
relative	Methotrexate	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	9	0.4444444444444444	6
relative	Methotrexate	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	12	0.8333333333333334	6
relative	Methotrexate	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	12	0.16666666666666666	6
relative	Methotrexate	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	9	0.6666666666666666	6
relative	Methotrexate	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	9	0.3333333333333333	6
relative	Methotrexate	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	12	0.75	6
relative	Methotrexate	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	12	0.25	6
relative	Methotrexate	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	9	0.7777777777777778	6
relative	Methotrexate	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	9	0.2222222222222222	6
relative	Methotrexate	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	12	0.75	6
relative	Methotrexate	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	12	0.25	6
relative	Methotrexate	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	9	0.6666666666666666	6
relative	Methotrexate	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	9	0.3333333333333333	6
relative	Methotrexate	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	12	0.75	6
relative	Methotrexate	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	12	0.25	6
relative	Methotrexate	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	9	0.6666666666666666	6
relative	Methotrexate	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	9	0.3333333333333333	6
relative	Methotrexate	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	12	0.75	6
relative	Methotrexate	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	12	0.25	6
relative	Methotrexate	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	9	0.6666666666666666	6
relative	Methotrexate	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	9	0.3333333333333333	6
relative	Methotrexate	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	6	1	6
relative	Methotrexate	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	15	0.8666666666666667	6
relative	Methotrexate	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	15	0.13333333333333333	6
relative	Methotrexate	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	6	1	6
relative	Methotrexate	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	15	0.7333333333333333	6
relative	Methotrexate	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	15	0.26666666666666666	6
relative	Methotrexate	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	6	1	6
relative	Methotrexate	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	15	0.7333333333333333	6
relative	Methotrexate	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	15	0.26666666666666666	6
relative	Methotrexate	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	6	1	6
relative	Methotrexate	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	15	0.6666666666666666	6
relative	Methotrexate	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	5	15	0.3333333333333333	6
relative	Methotrexate	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	6	1	6
relative	Methotrexate	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	15	0.9333333333333333	6
relative	Methotrexate	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	15	0.06666666666666667	6
relative	Methotrexate	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	6	1	6
relative	Methotrexate	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	15	0.9333333333333333	6
relative	Methotrexate	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	15	0.06666666666666667	6
relative	Niclosamide	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Niclosamide	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	19	0.2631578947368421	6
relative	Niclosamide	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	19	0.7368421052631579	6
relative	Niclosamide	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Niclosamide	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	19	0.2631578947368421	6
relative	Niclosamide	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	19	0.7368421052631579	6
relative	Niclosamide	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Niclosamide	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	19	0.3684210526315789	6
relative	Niclosamide	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	19	0.631578947368421	6
relative	Niclosamide	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Niclosamide	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	19	0.3684210526315789	6
relative	Niclosamide	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	19	0.631578947368421	6
relative	Niclosamide	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Niclosamide	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	19	0.5263157894736842	6
relative	Niclosamide	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	19	0.47368421052631576	6
relative	Niclosamide	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Niclosamide	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	19	0.3684210526315789	6
relative	Niclosamide	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	12	19	0.631578947368421	6
relative	Niclosamide	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Niclosamide	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	20	0.5	6
relative	Niclosamide	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	20	0.5	6
relative	Niclosamide	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Niclosamide	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	9	20	0.45	6
relative	Niclosamide	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	20	0.55	6
relative	Niclosamide	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Niclosamide	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	20	0.5	6
relative	Niclosamide	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	20	0.5	6
relative	Niclosamide	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Niclosamide	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	20	0.5	6
relative	Niclosamide	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	20	0.5	6
relative	Niclosamide	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Niclosamide	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	20	0.5	6
relative	Niclosamide	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	20	0.5	6
relative	Niclosamide	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Niclosamide	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	20	0.5	6
relative	Niclosamide	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	20	0.5	6
relative	Niclosamide	160	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Niclosamide	160	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	8	19	0.42105263157894735	6
relative	Niclosamide	160	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	19	0.5789473684210527	6
relative	Niclosamide	160	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Niclosamide	160	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	9	19	0.47368421052631576	6
relative	Niclosamide	160	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	19	0.5263157894736842	6
relative	Niclosamide	160	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Niclosamide	160	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	19	0.5263157894736842	6
relative	Niclosamide	160	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	19	0.47368421052631576	6
relative	Niclosamide	160	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Niclosamide	160	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	19	0.5263157894736842	6
relative	Niclosamide	160	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	19	0.47368421052631576	6
relative	Niclosamide	160	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Niclosamide	160	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	19	0.5263157894736842	6
relative	Niclosamide	160	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	19	0.47368421052631576	6
relative	Niclosamide	160	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Niclosamide	160	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	9	19	0.47368421052631576	6
relative	Niclosamide	160	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	19	0.5263157894736842	6
relative	Nifurtimox	2.5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	10	0.8	6
relative	Nifurtimox	2.5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	10	0.2	6
relative	Nifurtimox	2.5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	11	0.18181818181818182	6
relative	Nifurtimox	2.5	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	11	0.8181818181818182	6
relative	Nifurtimox	2.5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	10	1	6
relative	Nifurtimox	2.5	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	11	0.18181818181818182	6
relative	Nifurtimox	2.5	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	11	0.8181818181818182	6
relative	Nifurtimox	2.5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	10	1	6
relative	Nifurtimox	2.5	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	11	1	6
relative	Nifurtimox	2.5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	10	1	6
relative	Nifurtimox	2.5	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	11	1	6
relative	Nifurtimox	2.5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	8	10	0.8	6
relative	Nifurtimox	2.5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	10	0.2	6
relative	Nifurtimox	2.5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	11	0.36363636363636365	6
relative	Nifurtimox	2.5	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	11	0.6363636363636364	6
relative	Nifurtimox	2.5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	10	0.7	6
relative	Nifurtimox	2.5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	10	0.3	6
relative	Nifurtimox	2.5	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	11	0.36363636363636365	6
relative	Nifurtimox	2.5	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	11	0.6363636363636364	6
relative	Nifurtimox	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Nifurtimox	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	18	0.2777777777777778	6
relative	Nifurtimox	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	13	18	0.7222222222222222	6
relative	Nifurtimox	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	3	0.6666666666666666	6
relative	Nifurtimox	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	3	0.3333333333333333	6
relative	Nifurtimox	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	18	0.3888888888888889	6
relative	Nifurtimox	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	18	0.6111111111111112	6
relative	Nifurtimox	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Nifurtimox	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	18	0.05555555555555555	6
relative	Nifurtimox	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	17	18	0.9444444444444444	6
relative	Nifurtimox	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Nifurtimox	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	18	0.1111111111111111	6
relative	Nifurtimox	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	16	18	0.8888888888888888	6
relative	Nifurtimox	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	3	0.6666666666666666	6
relative	Nifurtimox	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	3	0.3333333333333333	6
relative	Nifurtimox	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	12	18	0.6666666666666666	6
relative	Nifurtimox	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	18	0.3333333333333333	6
relative	Nifurtimox	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	3	0.6666666666666666	6
relative	Nifurtimox	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	3	0.3333333333333333	6
relative	Nifurtimox	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	18	0.6111111111111112	6
relative	Nifurtimox	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	18	0.3888888888888889	6
relative	Nifurtimox	35	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	3	0.6666666666666666	6
relative	Nifurtimox	35	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	3	0.3333333333333333	6
relative	Nifurtimox	35	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	18	0.5555555555555556	6
relative	Nifurtimox	35	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	18	0.4444444444444444	6
relative	Nifurtimox	35	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Nifurtimox	35	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	9	18	0.5	6
relative	Nifurtimox	35	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	18	0.5	6
relative	Nifurtimox	35	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Nifurtimox	35	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	8	18	0.4444444444444444	6
relative	Nifurtimox	35	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	18	0.5555555555555556	6
relative	Nifurtimox	35	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Nifurtimox	35	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	18	0.2222222222222222	6
relative	Nifurtimox	35	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	18	0.7777777777777778	6
relative	Nifurtimox	35	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	3	0.6666666666666666	6
relative	Nifurtimox	35	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	3	0.3333333333333333	6
relative	Nifurtimox	35	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	14	18	0.7777777777777778	6
relative	Nifurtimox	35	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	4	18	0.2222222222222222	6
relative	Nifurtimox	35	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	3	0.6666666666666666	6
relative	Nifurtimox	35	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	3	0.3333333333333333	6
relative	Nifurtimox	35	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	15	18	0.8333333333333334	6
relative	Nifurtimox	35	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	18	0.16666666666666666	6
relative	Olanzapine	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Olanzapine	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
relative	Olanzapine	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
relative	Olanzapine	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Olanzapine	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Olanzapine	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Olanzapine	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Olanzapine	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Olanzapine	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Olanzapine	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Olanzapine	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Olanzapine	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Olanzapine	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Olanzapine	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Olanzapine	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Olanzapine	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Olanzapine	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
relative	Olanzapine	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
relative	Olanzapine	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	21	0.8095238095238095	6
relative	Olanzapine	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	21	0.19047619047619047	6
relative	Olanzapine	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	21	0.8571428571428571	6
relative	Olanzapine	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	21	0.14285714285714285	6
relative	Olanzapine	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Olanzapine	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Olanzapine	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Olanzapine	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Olanzapine	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	21	0.7142857142857143	6
relative	Olanzapine	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	6	21	0.2857142857142857	6
relative	Omeprazole	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Omeprazole	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Omeprazole	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Omeprazole	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Omeprazole	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Omeprazole	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Omeprazole	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Omeprazole	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
relative	Omeprazole	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
relative	Omeprazole	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Omeprazole	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Omeprazole	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
relative	Omeprazole	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
relative	Omeprazole	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
relative	Omeprazole	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
relative	Omeprazole	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Omeprazole	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Omeprazole	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	16	18	0.8888888888888888	6
relative	Omeprazole	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	18	0.1111111111111111	6
relative	Omeprazole	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	3	1	6
relative	Omeprazole	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	18	0.9444444444444444	6
relative	Omeprazole	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	18	0.05555555555555555	6
relative	Omeprazole	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	3	0.3333333333333333	6
relative	Omeprazole	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	3	0.6666666666666666	6
relative	Omeprazole	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	16	18	0.8888888888888888	6
relative	Omeprazole	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	18	0.1111111111111111	6
relative	Omeprazole	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	3	0.6666666666666666	6
relative	Omeprazole	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	1	3	0.3333333333333333	6
relative	Omeprazole	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	16	18	0.8888888888888888	6
relative	Omeprazole	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	18	0.1111111111111111	6
relative	Omeprazole	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	3	0.3333333333333333	6
relative	Omeprazole	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	2	3	0.6666666666666666	6
relative	Omeprazole	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	16	18	0.8888888888888888	6
relative	Omeprazole	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	18	0.1111111111111111	6
relative	Omeprazole	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	3	1	6
relative	Omeprazole	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	18	0.9444444444444444	6
relative	Omeprazole	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	18	0.05555555555555555	6
relative	Omeprazole	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	3	3	1	6
relative	Oxolinic acid	0.5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
relative	Oxolinic acid	0.5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
relative	Oxolinic acid	0.5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	18	21	0.8571428571428571	6
relative	Oxolinic acid	0.5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	21	0.14285714285714285	6
relative	Oxolinic acid	0.5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
relative	Oxolinic acid	0.5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
relative	Oxolinic acid	0.5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
relative	Oxolinic acid	0.5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
relative	Oxolinic acid	0.5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	16	21	0.7619047619047619	6
relative	Oxolinic acid	0.5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	5	21	0.23809523809523808	6
relative	Oxolinic acid	0.5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
relative	Oxolinic acid	0.5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
relative	Oxolinic acid	2.5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
relative	Oxolinic acid	2.5	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Oxolinic acid	2.5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
relative	Oxolinic acid	2.5	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Oxolinic acid	2.5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	20	1	6
relative	Oxolinic acid	2.5	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Oxolinic acid	2.5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	17	20	0.85	6
relative	Oxolinic acid	2.5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	20	0.15	6
relative	Oxolinic acid	2.5	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Oxolinic acid	2.5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	20	0.95	6
relative	Oxolinic acid	2.5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	20	0.05	6
relative	Oxolinic acid	2.5	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Oxolinic acid	2.5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	20	0.65	6
relative	Oxolinic acid	2.5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	7	20	0.35	6
relative	Oxolinic acid	2.5	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	1	1	6
relative	Oxolinic acid	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	14	18	0.7777777777777778	6
relative	Oxolinic acid	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	4	18	0.2222222222222222	6
relative	Oxolinic acid	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	3	1	6
relative	Oxolinic acid	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	18	0.7222222222222222	6
relative	Oxolinic acid	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	5	18	0.2777777777777778	6
relative	Oxolinic acid	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	3	1	6
relative	Oxolinic acid	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	18	0.8333333333333334	6
relative	Oxolinic acid	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	18	0.16666666666666666	6
relative	Oxolinic acid	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	3	1	6
relative	Oxolinic acid	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	15	18	0.8333333333333334	6
relative	Oxolinic acid	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	3	18	0.16666666666666666	6
relative	Oxolinic acid	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	3	1	6
relative	Oxolinic acid	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	13	18	0.7222222222222222	6
relative	Oxolinic acid	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	5	18	0.2777777777777778	6
relative	Oxolinic acid	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	3	1	6
relative	Oxolinic acid	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	12	18	0.6666666666666666	6
relative	Oxolinic acid	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	6	18	0.3333333333333333	6
relative	Oxolinic acid	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	3	1	6
relative	Sertindole	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Sertindole	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Sertindole	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Sertindole	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Sertindole	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Sertindole	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Sertindole	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Sertindole	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
relative	Sertindole	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
relative	Sertindole	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	7	1	6
relative	Sertindole	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	14	1	6
relative	Sertindole	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	7	1	6
relative	Sertindole	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	14	0.21428571428571427	6
relative	Sertindole	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	14	0.7857142857142857	6
relative	Sertindole	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	7	1	6
relative	Sertindole	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	14	1	6
relative	Sertindole	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	7	1	6
relative	Sertindole	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	14	1	6
relative	Sertindole	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	7	7	1	6
relative	Sertindole	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	14	1	6
relative	Sertindole	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	6	7	0.8571428571428571	6
relative	Sertindole	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	7	0.14285714285714285	6
relative	Sertindole	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	14	0.07142857142857142	6
relative	Sertindole	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	13	14	0.9285714285714286	6
relative	Sertindole	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Sertindole	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	18	0.16666666666666666	6
relative	Sertindole	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	15	18	0.8333333333333334	6
relative	Sertindole	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Sertindole	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	18	0.16666666666666666	6
relative	Sertindole	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	15	18	0.8333333333333334	6
relative	Sertindole	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Sertindole	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	18	18	1	6
relative	Sertindole	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Sertindole	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	18	0.16666666666666666	6
relative	Sertindole	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	15	18	0.8333333333333334	6
relative	Sertindole	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Sertindole	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	18	18	1	6
relative	Sertindole	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	3	3	1	6
relative	Sertindole	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	18	0.1111111111111111	6
relative	Sertindole	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	16	18	0.8888888888888888	6
relative	Simvastatin	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Simvastatin	5	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Simvastatin	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Simvastatin	5	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Simvastatin	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	19	21	0.9047619047619048	6
relative	Simvastatin	5	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	21	0.09523809523809523	6
relative	Simvastatin	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Simvastatin	5	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Simvastatin	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	20	21	0.9523809523809523	6
relative	Simvastatin	5	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	21	0.047619047619047616	6
relative	Simvastatin	5	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	21	21	1	6
relative	Simvastatin	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	11	0.8181818181818182	6
relative	Simvastatin	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	11	0.18181818181818182	6
relative	Simvastatin	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	10	1	6
relative	Simvastatin	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	11	0.8181818181818182	6
relative	Simvastatin	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	11	0.18181818181818182	6
relative	Simvastatin	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	10	0.2	6
relative	Simvastatin	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	10	0.8	6
relative	Simvastatin	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	6
relative	Simvastatin	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	6
relative	Simvastatin	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	10	0.1	6
relative	Simvastatin	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	10	0.9	6
relative	Simvastatin	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	11	11	1	6
relative	Simvastatin	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	10	10	1	6
relative	Simvastatin	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	9	11	0.8181818181818182	6
relative	Simvastatin	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	2	11	0.18181818181818182	6
relative	Simvastatin	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	1	10	0.1	6
relative	Simvastatin	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	10	0.9	6
relative	Simvastatin	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	10	11	0.9090909090909091	6
relative	Simvastatin	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	sensitized in community	FALSE	1	11	0.09090909090909091	6
relative	Simvastatin	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	10	0.2	6
relative	Simvastatin	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	10	0.8	6
relative	Simvastatin	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Simvastatin	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	5	19	0.2631578947368421	6
relative	Simvastatin	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	19	0.7368421052631579	6
relative	Simvastatin	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Simvastatin	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	11	19	0.5789473684210527	6
relative	Simvastatin	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	8	19	0.42105263157894735	6
relative	Simvastatin	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Simvastatin	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	19	0.3157894736842105	6
relative	Simvastatin	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	13	19	0.6842105263157895	6
relative	Simvastatin	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Simvastatin	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	19	0.5263157894736842	6
relative	Simvastatin	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	19	0.47368421052631576	6
relative	Simvastatin	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Simvastatin	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	13	19	0.6842105263157895	6
relative	Simvastatin	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	6	19	0.3157894736842105	6
relative	Simvastatin	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	2	2	1	6
relative	Simvastatin	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	12	19	0.631578947368421	6
relative	Simvastatin	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	7	19	0.3684210526315789	6
relative	Tamoxifen	20	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Tamoxifen	20	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	20	0.15	6
relative	Tamoxifen	20	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	17	20	0.85	6
relative	Tamoxifen	20	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Tamoxifen	20	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	20	0.15	6
relative	Tamoxifen	20	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	17	20	0.85	6
relative	Tamoxifen	20	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Tamoxifen	20	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	20	0.2	6
relative	Tamoxifen	20	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	16	20	0.8	6
relative	Tamoxifen	20	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Tamoxifen	20	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	20	0.2	6
relative	Tamoxifen	20	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	16	20	0.8	6
relative	Tamoxifen	20	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Tamoxifen	20	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	20	0.1	6
relative	Tamoxifen	20	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	18	20	0.9	6
relative	Tamoxifen	20	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Tamoxifen	20	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	20	0.15	6
relative	Tamoxifen	20	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	17	20	0.85	6
relative	Tamoxifen	80	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Tamoxifen	80	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	20	0.2	6
relative	Tamoxifen	80	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	16	20	0.8	6
relative	Tamoxifen	80	LM1844	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Tamoxifen	80	LM1844	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	9	20	0.45	6
relative	Tamoxifen	80	LM1844	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	11	20	0.55	6
relative	Tamoxifen	80	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Tamoxifen	80	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	20	0.35	6
relative	Tamoxifen	80	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	13	20	0.65	6
relative	Tamoxifen	80	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Tamoxifen	80	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	6	20	0.3	6
relative	Tamoxifen	80	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	14	20	0.7	6
relative	Tamoxifen	80	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Tamoxifen	80	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	20	0.35	6
relative	Tamoxifen	80	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	13	20	0.65	6
relative	Tamoxifen	80	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	6
relative	Tamoxifen	80	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	7	20	0.35	6
relative	Tamoxifen	80	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	13	20	0.65	6
relative	Tamoxifen	320	LM1844	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	5
relative	Tamoxifen	320	LM1844	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	10	19	0.5263157894736842	5
relative	Tamoxifen	320	LM1844	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	9	19	0.47368421052631576	5
relative	Tamoxifen	320	LM1847	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	5
relative	Tamoxifen	320	LM1847	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	19	0.10526315789473684	5
relative	Tamoxifen	320	LM1847	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	17	19	0.8947368421052632	5
relative	Tamoxifen	320	LM1847	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	5
relative	Tamoxifen	320	LM1847	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	3	19	0.15789473684210525	5
relative	Tamoxifen	320	LM1847	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	16	19	0.8421052631578947	5
relative	Tamoxifen	320	LM1857	1	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	5
relative	Tamoxifen	320	LM1857	1	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	2	19	0.10526315789473684	5
relative	Tamoxifen	320	LM1857	1	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	17	19	0.8947368421052632	5
relative	Tamoxifen	320	LM1857	2	FALSE	sensitization (fraction of single-species non-hits)	expected (normal growth in both cases)	TRUE	1	1	1	5
relative	Tamoxifen	320	LM1857	2	TRUE	protection (fraction of single-species hits)	expected (reduced growth in both cases)	TRUE	4	19	0.21052631578947367	5
relative	Tamoxifen	320	LM1857	2	TRUE	protection (fraction of single-species hits)	protected in community	FALSE	15	19	0.7894736842105263	5
